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Enzymes have been used for decades for the industrial production of high value chemicals 
such as food additives, antibiotics and other pharmaceutical products. However, in recent years 
the significant advances in biocatalyst development have led to a rise in the number of commodity 
chemicals being produced by enzymes instead of extraction from plants or chemical synthesis. 
Such products include biodiesel and wax esters.  
For this industrial exploitation of enzymes, it is vital to have an extensive understanding of 
how the desired enzymes work, including what the enzymes’ substrate preferences and stability 
are. This knowledge comes from the structural and biochemical characterization of these 
biocatalysts, and this is the scope of this dissertation; to broaden our knowledge and understanding 
of enzymes that are involved in the biosynthesis of value-added products, such as biodiesel and 
drugs. 
Biodiesel is a mixture of long chain fatty acid alkyl esters (FAAEs), produced mainly by the 
transesterification of fatty acids derived from vegetable oils and animal fats. In recent years, 
biodiesel has emerged as a viable resource for utilization in green energy production. However, 
current production processes utilize methods that are cost ineffective and generate waste 
byproducts. Recent progress in the field makes use of biocatalysts that are effective in diverting 
products from primary metabolism to yield fatty acid methyl and ethyl esters in bacterial systems 
(as well as other commodity chemicals). Two of these enzymes have been the focus of my study: 
a fatty acid O-methyltransferase (FAMT) from Mycobacterium marinum (MmFAMT), and a 
bifunctional wax ester synthase/diacylglycerol acyl-transferase (WS/DGAT) from Marinobacter 
aquaeolei VT8 (Ma-WS/DGAT).  
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In Chapter 1, I present the first kinetic and structural characterization of a mycobacterial 
fatty acid O-methyltransferase (MmFAMT) previously utilized for the production of biodiesel in 
E. coli. The structure revealed unexpected similarity with methyltransferases from plant natural 
product metabolism, and an active-site cavity that can accommodate fatty acids up to 12-14 
carbons long. Our results provide the framework for further optimization of an in vivo system that 
utilizes MmFAMT for production of biodiesel.  
In Chapter 2, I discuss the structure of a bifunctional wax ester synthase/diacylglycerol acyl-
transferase (Ma-WS/DGAT), which is to our knowledge the first structure for any member of this 
enzyme family to date. Wax esters (WE) are esters of long chain fatty acids and long chain alcohols 
and have widely been used in cosmetics, lubricants, candles and the food industry. In addition, WE 
that consist of medium chain fatty acids and ethanol (fatty acid ethyl esters, FAEEs) are biodiesel. 
Today, there is a strong demand for the development of a large-scale process for the production of 
low cost WE. The structure may facilitate future engineering efforts aiming at the optimization of 
this biocatalyst towards production of desired wax esters for industrial use. 
In addition to biodiesel, value-added chemicals produced by enzymes include bioactive 
compounds such as chemotherapeutics and antibiotics. In Chapters 3 and 4, I present structural 
and biochemical data that expand our knowledge for enzymes involved in the biosynthesis of such 
compounds. 
In Chapter 3, I discuss the molecular basis for the substrate specificity of loganic acid O-
methyltransferase from Catharanthus roseus (CraLAMT), an enzyme that methylates with high 
stereospecificity an iridoid glycoside to produce loganin. Loganin is an intermediate in the 
biosynthesis of indole alkaloids in plants - a group of plant natural products with several medicinal 
uses, and has attracted interest as a bioactive compound itself. Our results may facilitate future 
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engineering efforts to diversify the CraLAMT substrate scaffold towards the design of new 
potential bioactive compounds. 
In Chapter 4, I present structural and biochemical data for enzymes that are involved in the 
biosynthesis of phosphonates. Phosphonates are natural products containing a carbon-phosphorous 
(C-P) bond. These C-P containing molecules inhibit enzymes which utilize phosphate esters and 
carboxylic acids by mimicking their substrates. At a time when drug-resistant pathogens pose 
serious threat to human health, phosphonate natural products provide a pool of potential 
therapeutic candidates. Two such phosphonate containing compounds are rhizocticin and 
plumbemycin.  
Rhizocticin and plumbemycin are di- or tripeptides that contain the same phosphonic amino 
acid at their C-termini, but differ at their N-termini. This unusual amino acid is (Z)-L-2-amino-5-
phosphono-3-pentenoic acid (APPA), and is the active part of rhizocticin and plumbemycin. Upon 
entering the cell, host peptidases release APPA which subsequently inhibits threonine synthase 
(ThrC) and kills the cell. Because thrC is an essential gene in bacteria and fungi, but is absent in 
humans, rhizocticin and plumbemycin are attractive as potential antimicrobials. In Chapter 4, I 
present data that provide insight into the mechanism of inhibition of ThrC by APPA. In addition, 
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CHAPTER 1: STRUCTURAL AND BIOCHEMICAL 
STUDIES OF A MYCOBACTERIAL FATTY ACID 
METHYLTRANSFERASE1 
1.1 Introduction 
The increasing demand for energy, coupled with the need for energy independence and 
security, have been the main forces driving the growing interest in the use of biofuels as a potential 
sustainable energy resource. The Energy Independence and Security Act of 2007 (EISA) mandates 
increased production of biofuels with the aim of reducing the national dependence on unstable 
foreign suppliers, as well as reducing pollutants produced by the consumption of fossil fuels [1]. 
Although biofuels hold great promise, the current methodologies used for their production require 
large quantities of water, fertilizers and pesticides rendering biofuels less environment-friendly 
and sustainable than desired [2]. 
In recent years, biodiesel has emerged as a viable resource for utilization in green energy 
production. In addition to favorable properties such as biodegradability and low toxicity, biodiesel 
has properties similar to those of petro-diesel, and can be used as a motor fuel without major engine 
modifications [3]. It is a mixture of long chain fatty acid alkyl esters (FAAEs), produced mainly 
by the transesterification of fatty acids derived from vegetable oils and animal fats [4]. These 
                                                          
1 This chapter is adapted from the following published article: 
 
Nektaria Petronikolou & Satish K. Nair (2015). Biochemical Studies of Mycobacterial Fatty Acid Methyltransferase: A Catalyst for the Enzymatic 




biodiesel precursors are esters of three fatty acids with glycerol, known as triglycerides (TGs), 
which can undergo transesterification with an alcohol in the presence of a catalyst to yield FAAEs 
and glycerol as final products. However, this process is expensive and generates waste, negating 
the financial and environmental benefits of using biodiesel [5]. 
With the goal of formulating less energy intensive and more environment-friendly methods 
for biodiesel production, several laboratories have engineered microorganisms for overproduction 
of fatty acids [6-9]. More recently, E. coli has been engineered to directly produce fatty acid methyl 
Figure 1. 1: Reactions catalyzed by the fatty acid O-methyltransferase (FAMT) and two of its 
structural homologs from the SABATH family (7-MXMT: 7-methylxanthine N-methyltransferase, 
SAMT: salicylic acid O-methyltransferase). Free fatty acids can be released by the action of a 
thioesterase (TES) on acyl-ACP (ACP: Acyl Carrier Protein). 
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esters (FAMEs) and 3-hydroxy fatty acid methyl esters (3-OH FAMEs) by using a fatty acid O-
methyltransferase (FAMT) from Mycobacterium marinum (MmFAMT) (Figure 1. 1) [9]. 
Although the yield of FAMEs produced by this pathway was lower than the maximal FAAEs 
yields reported [7, 9], the use of FAMT holds promise for in vivo biodiesel production.  
The fatty acid O-methyltransferases are S-adenosylmethionine (SAM) dependent enzymes 
that catalyze the transfer of a methyl group to the carboxyl group of a fatty acid acceptor [10]. As 
SAM dependent methyltransferases have important implications for health, the reaction 
mechanism and structure of these enzymes are well studied and characterized [11]. Mycobacteria 
specifically possess a large number of SAM dependent methyltransferases that catalyze the 
modification of mycolic acids, the very long fatty acids found in mycobacterial cell walls [12]. 
These enzymes can be broadly classified with regards to the identity of the methyl acceptor, and 
include the cyclopropane fatty acid synthases (which catalyze C-methylation of a cis double bond) 
[13], and the O-methyltransferases that catalyze methylation on the hydroxyl moiety of 
phthiocerol, phenolphthiocerol, or ketomycolate [14, 15]. There are three cyclopropane fatty acid 
synthases with different regiospecificities; CmaA1 catalyzes the installation of the distal 
cyclopropane ring on α-mycolic acid when overexpressed [16, 17], PcaA installs that proximal 
cyclopropane ring in α-meroacid [18], and CmaA2 catalyzes the cis-cyclopropane synthesis in 
methoxy-mycolates [15]. Additional examples include MmaA4 that introduces a methyl branch, 
together with an adjacent hydroxyl group during the formation of both keto- and 
methoxymycolates [19]. In contrast to these other SAM-dependent enzymes, little is known about 
fatty acid O-methyltransferases (FAMTs) [9, 20-23]. While they were first discovered in 
Mycobacteria in 1970 [20], there are very few studies published about this class of 
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methyltransferases [9, 20, 22], and their physiological role in Mycobacteria has yet to be 
elucidated.  
The identification of the mycobacterial FAMTs was facilitated by the sequence analysis of 
mycobacterial proteins, which suggested that the structure contains Rossman-like fold found in 
class I methyltransferases [24]. The primary sequences of the mycobacterial enzymes also suggest 
weak, but notable, similarities to plant natural product methyltransferases, such as 
dimethylxanthine methyltransferase, (PDB code 2EFJ) [25], salicylate methyltransferase (PDB 
code 1M6E) [26], as well as other members of a recently characterized protein family classified as 
the SABATH methyltransferase (Pfam03492 [27]; so named for the first characterized members 
of this fold class) (Figure 1. 1). However, these plant enzymes are not known to catalyze 
methylation of fatty acid substrates, and the sequence identity between the mycobacterial enzymes 
and the plant O-methyltransferases is less than 25%.  
In order to understand the basis for this biotechnologically relevant enzyme, we carried out 
biochemical and biophysical characterization of the MmFAMT that has been previously utilized 
for the in vivo production of biodiesel [9]. Cocrystal structures of the enzyme with a variety of 
bound substrates allow for the identification of features that bestow specificity to fatty acid 
substrates. Kinetic characterization of active site variants, as deduced from the structural data, 
facilitates the assignment of roles for various residues and the proposal for a reaction mechanism 
consistent with the data. These studies should provide a framework for future engineering 






1.2 Materials and Methods 
Chemicals and Reagents 
All chemical reagents were purchased from Sigma-Aldrich unless otherwise noted. All of 
the material used for protein production and purification were purchased from GE Healthcare. 
 
Cloning and Site-Specific Mutagenesis 
MmFAMT (GenBank accession number NC010612 – gene MMAR3356) was amplified 
using the PCR with template genomic DNA of Mycobacterium marinum strain M (ATCC BAA-
535) and primers designed based on the published sequence. The gene was inserted into the 
NdeI/BamHI sites of a pET28b vector, and this plasmid was used as template for the generation 
of the site-specific mutants by PCR (Table A. 1). The integrity of all recombinant plasmids was 
confirmed by sequencing (ACGT, Inc.). 
 
Protein Expression and Purification 
Expression vectors bearing wild type or mutant MmFAMT were transformed into E. coli 
Rosetta 2(DE3) cells for heterologous protein production. A 5 ml starter culture was inoculated in 
2L Luria-Bertani growth medium supplemented with 50 µg/mL kanamycin and 25 µg/mL 
chloramphenicol. The culture was grown at 37 °C until the absorbance at 600 nm reached 0.6 – 
0.8, at which point protein production was induced by addition of 0.3 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). The culture was then cooled to 18 °C and grown for an additional 
18 h. Cells were collected by centrifugation, resuspended in 20 mM Tris-HCl (pH 8.0), 500 mM 
NaCl, and 10% glycerol buffer, and lysed by multiple passages through a C5 Emulsiflex (Avestin) 
cell homogenizer. Following centrifugation of the lysate, the supernatant was applied to a 5 ml 
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His-Trap (GE Biosciences) column that was previously equilibrated with 20 mM Tris-HCl (pH 
8.0), 1 M NaCl, and 30 mM imidazole. The column was extensively washed with the same buffer 
and elution of specifically bound protein was carried out using a gradient of increasing imidazole 
concentration. Fractions containing protein of the highest purity (as determined by SDS-PAGE) 
were pooled and the polyhistidine affinity tag was removed by overnight incubation with thrombin 
at 4 °C. Samples were further purified using size exclusion chromatography (Superdex Hiload 200 
16/60) in a buffer of 20 mM HEPES-KOH, pH 7.5, 300 mM KCl. Samples were concentrated 
using a 10,000 Da molecular weight cutoff Amicon centrifugal filters. Selenomethionine-labeled 
(SeMet) MmFAMT was produced by repression of methionine biosynthesis in defined media prior 
to protein induction [28], and was purified as described above. All proteins were flash frozen in 
liquid nitrogen and stored at -80 °C. Prior to freezing, 2.5% glycerol (final concentration) was 
added to samples of wild type and mutant proteins used for kinetic analysis, but not to samples 
used for crystallographic studies. 
 
Crystallization 
Initial crystallization conditions were determined by the sparse matrix sampling method 
using commercial screens. Crystals of the MmFAMT-SAH complex were grown using the hanging 
vapor drop diffusion method. Briefly, 0.9 μl of protein at 4 mg/ml concentration was incubated 
with 2 mM SAM for 1 h on ice, and was subsequently mixed with 0.9 μl of precipitant solution 
(0.1 M MgCl2, 0.1 M ADA, pH 6.5, 12% PEG 6,000) and 0.2 μl of 7% v/v 1-butanol, and 
equilibrated over a well containing the same precipitant solution at room temperature. Crystals 
grew within 2 days, and were transiently soaked in precipitant solution supplemented with 30% 
glycerol prior to vitrification by direct immersion in liquid nitrogen. Ligand bound crystals were 
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grown similarly using protein that was incubated with 2mM SAH, 2mM (3-hydroxy) fatty acid 
and 1mM DTT for 30 minutes prior to crystallization. 
 
Data Collection, Phasing and Structure Determination 
X-ray diffraction data were collected at Life Sciences Collaborative Access Team (LS-
CAT), Sector 21, Argonne National Laboratory. All data were indexed, integrated and scaled using 
either HKL2000 or XDS. Initial crystallographic phases were determined by single wavelength 
anomalous diffraction from the SeMet-labeled protein crystals of the MmFAMT-SAH complex 
using data collected near the Se absorption edge (λ=0.97872 Å). Due to the low symmetry of the 
SeMet crystals (monoclinic setting) care was taken during crystal alignment to maximize the 
simultaneous collection of Bijvoet pairs. A four-fold redundant data set was collected to 1.95 Å 
resolution (R-merge of 5.5%, I/σ(I) of 2.2 in the highest resolution shell) using a MAR CCD 
detector. The heavy atom substructure was determined using SHELX [29]. The heavy atom 
positions were imported into SHARP [30] for maximum likelihood refinement resulting in 
preliminary phases with a mean Figure of Merit of 0.382. Density modification using solvent 
flattening and non-crystallographic symmetry averaging yielded a map of exceptional quality, 
which allowed for near all of the main chain and roughly half of the side chains to be automatically 
built using Buccanneer [31, 32] as implemented in the CCP4 suite of programs [33]. Additional 
cycles of manual rebuilding interspersed with crystallographic refinement using REFMAC5 [34] 
resulted in the final model. The final cycles of model building and refinement were carried out 
against high-resolution data collected on native crystals of MmFAMT-SAH. 
Cocrystal structures with bound ligands were all determined by molecular replacement as 
implemented in the Phenix program suite [35], using the refined coordinates of SeMet MmFAMT 
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as search model. The resultant solutions were subsequently used as starting models for several 
rounds of automated model building using the ARP/wARP web server [33, 34, 36], followed by 
rounds of manual rebuilding using Coot [37], combined with crystallographic refinement using 
REFMAC5 [34]. Ligands were built in Coot, and water molecules were added using the 
ARP/wARP solvent building software of the CCP4 suite [38], and confirmed by manual 
inspection. In all cases, the quality of the in-progress model was routinely monitored using both 
the free R factor [39] and Molprobity [40] for quality assurance. 
 
Determination of Kinetic Parameters 
For all experiments, freshly purified protein was used, and SAM was further purified by 
HPLC using a C18 column (Vydac; 5 μm particle size, 4.6 × 250 mm) and monitoring absorbance 
at 260nm. The column was washed for 30 minutes with solvent B (methanol with 0.1% 
trifluoroacetic acid), and equilibrated for 15 minutes with solvent A (water with 0.1% 
trifluoroacetic acid). SAM was injected into the column and a gradient elution was applied as 
follows: wash with 5 ml of solvent A, elute with a linear gradient to a final 20% of solvent B, and 
wash with 5 ml of solvent B. The flow rate was 1 ml/min throughout the procedure. The fraction 
of SAM collected was subsequently lyophilized, and stored in -20 °C. Fresh solution of SAM was 
prepared before each experiment. 
The kinetic parameters of the wild type and mutant proteins were determined by using a 
photospectrometric assay that monitors the production of SAH [41, 42]. All enzyme reactions were 
performed in 100 mM HEPES-KOH (pH 7.8) and 300 mM KCl at 37 °C, and monitored at 265 
nm for up to 20 min. Control reactions without addition of the substrate were also included to take 
into account any background hydrolysis of SAM over time. For determination of the Michaelis-
9 
 
Menten parameters of the wild type enzyme and mutants for the fatty acids and 3-hydroxy fatty 
acids, a 150 μl reaction volume contained the following components: 0.1 – 2.0 μM MmFAMT, 1 
μM SAH nucleosidase, 0.2 μM adenine deaminase, 1 mM MnSO4, 80 μM SAM, and various 
concentrations of fatty acids and 3-hydroxy fatty acids. For determination of the kinetic parameters 
for SAM, a 150 μl reaction volume contained 0.2 μM MmFAMT, 1 μM SAH nucleosidase, 0.2 
μM adenine deaminase, 1 mM MnSO4, 3 mM of octanoic acid (C8) and various concentrations of 
SAM. Based on the initial reaction rates, the apparent KM and Vmax values were determined using 
the Michaelis-Menten function of Origin (OriginLab, Northampton, MA). Results are means ± 
SEM of triplicate experiments.  
For mutants with very increased KM values for C8 or 3-hydroxy-decanoic acid (3-OH-C10), 
saturation of the enzyme could not be achieved due to limited solubility of the substrates in the 
reaction buffer. In these cases, the apparent KM and Vmax values could not be determined, but the 
kcat/KM values were obtained by plotting the observed rates (kobs) at 4 different substrate 
concentrations (Figure 1. 2A). For the Tyr24Ala mutant, the kinetic parameters for SAM, and 
consequently for C8 and 3-OH-C10, could not be determined as the KM value increased such that 
saturation of the enzyme could not be achieved due to limitations of the assay (concentration of 
SAM used should be kept below 250 μM to remain in the linear range of the spectrophotometer 
[41]). 
To attest that the coupling enzymes were not rate-limiting, the initial rates of 0.1, 0.2 and 
0.4 μM of wild type enzyme were determined by addition of 3 mM C8. The means of the observed 
rates ± SEM were found to be the same (Figure 1. 2A), indicating that the coupling enzymes are 
not rate limiting. Consequently, the measured rate corresponds to the rate of MmFAMT. 
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All substrates were purchased from Sigma-Aldrich, except for the 3-OH-C8, which was 
purchased from Matreya, LLC. The 3-hydroxy fatty acids were purchased as enantiomeric 
mixtures. However, it is clear from the crystal structure of the enzyme complexed with SAH and 
3-OH-C10 that the enzyme utilizes only the S enantiomer (Figure 1. 6C and Figure A. 2). 
Subsequently, the enantiomeric ratio was determined by Mosher ester analysis [43], and was found 





Figure 1. 2: (A) Observed rates at 3 different enzyme concentrations for 3mM octanoate. All rates 
are the same indicating that the coupling enzymes are not limiting. (B, C) Michaelis-Menten 
kinetic plots for the mutant Q154A for octanoate (C8) and 3-hydroxydecanoate (3-OH-C10). (D, 
E, F) Observed rates at 4 different enzyme concentrations for the Y24F and W155F mutants. The 
slope of the plot corresponds to the kcat/KM value.  
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End-Point Activity Assay 
The activity of the wild type enzyme for salicylic acid (SA) was investigated by gas 
chromatography-mass spectroscopy (GC/MS). 100 μl reactions containing 50 μM wild type 
MmFAMT, 500 μM SAH nucleosidase, 5 mM SAM and 10 mM substrate were incubated at 37 
°C for 2 h. The samples were cleaned from the enzyme with a 10,000 Da molecular weight cutoff 
Amicon spin filter, and analyzed by the Roy J. Carver Biotechnology Center (University of Illinois 
at Urbana-Champaign). All reactions were performed in the same buffer used for kinetic analysis 
supplemented with 5% methanol (final concentration). To confirm that methanol did not deactivate 
the enzyme and possible observed inactivity was not due to its addition, reactions containing wild 
type MmFAMT and C8 were included. Control reactions without addition of the enzyme were also 
analyzed. Results are means ± SEM of triplicate experiments.  
 
Isothermal Titration Calorimetry (ITC) 
The binding affinity of wild type MmFAMT for SAM and SAH was measured at 25 °C 
using a VP-ITC microcalorimeter (Microcal Inc., Northampton, MA). Protein and ligands were in 
the same buffer used for kinetic analysis. For binding of SAM, 1.1 – 1.15 mM SAM was injected 
into the reaction cell containing 30 – 35 μΜ protein in 28 successive aliquots at 300 s intervals and 
20.5 s duration with a reference power of 2 μCal/s. For binding of SAH, 0.52 – 0.54 mM SAH was 
injected into the reaction cell containing 40 – 42 μΜ protein in 28 successive aliquots at 240 s 
intervals and 20.5 s duration with a reference power of 6 μCal/s. All injections were 10 μl in 
volume, except for the first injection which was 4 μl and was excluded from data analysis. The 
protein-ligand buffer was used in the reference cell, and a titration of the ligand into just the buffer 
was subtracted from the measurements. Non-linear regression with a single-site fitting model 
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(MicroCal Origin) was applied for data analysis, and the thermodynamic parameters were 
calculated using the Gibbs free energy equation (ΔG= ΔH – TΔS) and the relationship ΔG= -
RTlnKa. Results are means ± SEM of duplicate experiments. 
For the binding experiments, freshly purified protein was used, and SAM was further 
purified by HPLC using a C18 column (Vydac; 5 μm particle size, 4.6 × 250 mm) and monitoring 
absorbance at 260 nm. The column was washed for 30 minutes with solvent B (methanol with 
0.1% trifluoroacetic acid), and equilibrated for 15 minutes with solvent A (water with 0.1% 
trifluoroacetic acid). SAM was injected into the column and a gradient elution was applied as 
follows: wash with 5 ml of solvent A, elute with a linear gradient to a final 20% of solvent B, and 
wash with 5 ml of solvent B. The flow rate was 1 ml/min throughout the procedure. The fraction 
of SAM collected was subsequently lyophilized, and stored in -20 °C. Fresh solution of SAM was 
prepared before each experiment. 
 
Sequence Similarity Network 
A sequence similarity network was generated by using the Enzyme Function Initiative - 
Enzyme Similarity Tool (http://efi.igb.illinois.edu/efi-est/) [44] with the sequence of MmFAMT 
as the query for a BLASTP [45, 46] search of the UniProtKB database (http://www.uniprot.org/) 
[47]. Only sequences of 300-450 amino acids were included for the subsequent generation of a 
network with E-values equal to or lower than 1x10-30. This network was visualized using 






1.3 Results and Discussion 
Kinetic Characterization of M. marinum FAMT 
The kinetic parameters for wild type M. marinum FAMT (MmFAMT) for a panel of fatty 
acid and 3-hydroxy fatty acids were determined using a coupled assay [41, 42] that monitored 
SAM turnover. In this assay, S-adenosylhomocysteine (SAH), the product of SAM, gets 
hydrolyzed by an SAH nucleosidase (the SAH nucleosidase utilized has a catalytic efficiency of 
11.6 × 106 M-1s-1 [49], which is greater than that of MmFAMT) to S-ribosylhomocysteine and 
adenine. The latter is subsequently deaminated by an adenine deaminase resulting in a decrease in 
absorbance at 265 nm (Δε ≈ 6,700 M-1cm-1), and allowing for continuous monitoring of the 
reaction [41]. The catalytic efficiency of MmFAMT for free fatty acids was found to increase with 
chain length (the kcat/KM values for C8 octanoic acid is 1.49 × 103 M-1s-1; and for C10 decanoic 
acid is 2.97 × 104 M-1s-1) (Table 1. 1 and Figure 1. 3). The 3-hydroxy compounds were turned over 
less efficiently, with kcat/KM values that are roughly an order of magnitude lower than for the 
corresponding fatty acid. The kinetic parameters for MmFAMT reported here differ from values 
determined previously via a discontinuous assay that employed radiolabeled SAM as a donor [9]. 
These differences likely arise from variations in the two methods used for characterization. 
However, in the context of this work, our kinetic data provide an internal standard for analyzing 





Table 1. 1: Steady state kinetic parameters for MmFAMT wild type and mutants against different 
substrates. 
MmFAMT KM (μM) kcat (10-2s-1) kcat / KM (M-1s-1) 
WT    
C8 308 ± 9 46.1 ± 0.5 1,497 
C10 8.2 ± 0.5 24.4 ± 0.4 29,756 
3-OH-C8 2,039 ± 172 48.8 ± 1.4 239 
3-OH-C10 201 ± 8 59.9 ± 1.1 2,975 
SAM 25.5 ± 4.0 59.8 ± 3.2 23,450 
Q31A    
C8 * * * 
3-OH-C10 * * * 
Q154A     
C8 5,238 ± 427 14.7 ± 0.4 28.1 
3-OH-C10 1,028 ± 43 4.2 ± 0.0  40.9 
W155F    
C8 * * 1.37 ± 0.03 
3-OH-C10 * * 3.05 ± 0.16 
Y24F    
SAM * * 824 ± 19 




Binding Affinity of MmFAMT for SAM and SAH 
The product SAH is known to inhibit some SAM-dependent methyltransferases. In order to 
characterize if MmFAMT is similarly subject to product inhibition, we carried out isothermal 
titration calorimetric analysis to measure the binding affinity to SAM and SAH (Table 1. 2 and 
Figure 1. 4). MmFAMT binds to SAM with a dissociation constant (Kd) of 33.6 μM, while binding 
of SAH occurs with a Kd that is two orders of magnitude smaller (0.70 μM). For both ligands, 
binding is driven largely by the enthalpic component. These data are consistent with the inhibition 
of MmFAMT by the product SAH. It should be noted that all measurements using SAM as the 
ligand yielded a number of binding sites of (N = 2.06 +/- 0.01), while measurments with SAH gave 
a number of sites of (N = 0.93 +/- 0.01). The basis for this discrepancy is not clear, as the structural 
Figure 1. 3: Michaelis-Menten kinetic plots for the wild type MmFAMT for octanoate (C8), 
decanoate (C10), 3-hydroxyoctanoate (3-OH-C8) and 3-hydroxydecanoate (3-OH-C10). 
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data do not reveal evidence for multiple binding sites. Nonetheless, it is evident from the binding 
isotherms that MmFAMT binds tightly to SAH. These results are in agreement with product 
inhibition observed in several members of this family [50-52]. Hence, both in vivo and in vitro 
efficacy of enzymatic methylation of free fatty acids using FAMTs may be improved if the 
reactions were coupled to an S-adenosylhomocysteine nucleosidase to hydrolyze the SAH product. 
 
Table 1. 2: ITC binding parameters for wild type MmFAMT to SAH and SAM. 
Ligand N Ka (M-1) x104 Kd (M ) x10-7 ΔH (cal/mol) x103 
ΔS 
(cal/mol/deg) 
SAH 0.93 ± 0.01  143.5 ± 3.5  6.97 ± 0.17 -22.3 ± 0.6 -46.5 ± 2.1 
SAM 2.06 ± 0.01 3.0 ± 0.4 335.8 ± 45.0 -4.4 ± 0.3 5.8 ± 0.6 
Figure 1. 4: Representative ITC data for binding of MmFAMT to (A) SAM and (B) SAH. 
17 
 
Crystal Structures of MmFAMT 
The unique specificity of bacterial FAMTs for fatty acid substrates cannot be understood in 
the context of the distantly related plant SABATH family of methyltransferases, which share 
limited sequence similarities (25% sequence identity) and function on small molecule natural 
products [24]. In order to understand this substrate specificity and scope, we determined several 
binary and ternary complex structures of MmFAMT in complex with SAH (1.7 Å resolution), 
SAH and octanoate (1.6 Å resolution), and SAH and 3-hydroxydecanoate (1.9 Å resolution). We 
also determined the structure of an MmFAMT active site mutant (Gln154Ala) in complex with 
SAH and 3-hydroxydecanoate (1.85 Å resolution). Initial crystallographic phases were determined 
by single-wavelength anomalous diffraction using SeMet labeled protein (SAH and decanoic 
acid), and phases for subsequent structures were determined by molecular replacement using the 
resultant model as a search probe. All crystallographic data collection and refinement statistics are 
provided in Table 1. 3. 
Figure 1. 5: (A) Ribbon diagram of the MmFAMT-SAH crystal structure with one monomer 
colored in gray and the other colored in purple (Rossmann fold-like domain) and cyan (capping 
domain). (B) Simulated annealing difference Fourier map (Fo-Fc) contoured to 2.5σ (blue) and 
10σ (red) showing the SAM-binding site of MmFAMT. The coordinates for bound SAH were 
omitted during map calculations. The bound ligand is colored in yellow and residues that interact 
with the ligand are colored in gray. 
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Table 1. 3: Data collection, phasing and refinement statistics (1. Highest resolution shell is shown 
in parenthesis, 2. Rsym = Ʃ |(Ii - <Ii>| Ʃ Ii where Ii = intensity of the ith reflection and <Ii> = mean 
intensity, 3. Mean figure of merit (acentric/centric), 4. R-factor = Ʃ (|Fobs|-k|Fcalc|)/Ʃ |Fobs| and R-
free is the R value for a test set of reflections consisting of a random 5% of the diffraction data not 
used in refinement). 
 
 Native SeMet C8 3-OH-C10 Q154A-3-OH-C10 
       
Data collection      
Space Group P21 P21 P21 P21 P21 
 a, b, c (Å), β (o) 
63.1, 66.1, 98.4, 
107.5 
62.7, 65.7, 97.5, 
107.8 
63.1, 66.1, 98.1, 
107.4 
62.8, 65.9, 98.2, 
107.1 
62.8, 65.6, 98.2, 
107.3 
Resolution (Å)[1] 50-1.7 (1.73-1.7) 50-1.95 (1.98-1.95) 50-1.6 (1.63-1.6) 50-1.9 (1.93-1.9)  50-1.85 (1.88-1.85) 
Rsym (%)[2] 5.4 (52.1) 5.5 (58.8) 6.0 (57.3) 6.5 (54.1) 7.0 (81.4) 
I/σ(I) 25.6 (2.6) 15.9 (2.2) 20.5 (1.9)  18.2 (2.1) 14.5 (1.9) 
Completeness (%) 100 (99.9) 100 (100) 100 (99.7)  99.5 (100) 100 (100) 
Redundancy 5.0 (4.8) 4.1 (4.1) 4.2 (3.5) 4.1 (4.1) 4.7 (4.7) 
 
Phasing 
    
 
FOM[3]  0.382/0.157    
 
Refinement 
    
 
Resolution (Å) 25.0-1.7   25.0-1.6  25.0-1.9 25.0-1.85 
No. reflections 80,265   95,148 55,801 61,413 
Rwork / Rfree[4] 19.5/22.2   19.5/21.8  19.3/23.1 19.3/22.4 
 




Protein 5504   5533  5525 5525 
Fatty acid -   20 26 44 
SAH 52   52 52 52 






Protein 16.7   16.9 24.1  23.9 
Fatty acid -   16.2 17.2 22.2 
SAH 7.9   8.1 12.8 12.6 






Bond lengths (Å) 0.000   0.005 0.006 0.006 
Bond angles () 
 
1.07  1.07 1.15 1.11 
 
The overall structure of MmFAMT consists of a di-domain architecture composed of a 
Rossmann-like α/β fold that is common amongst diverse class I methyltransferases, which is 
19 
 
further elaborated with an all α-helical domain that caps the SAM-binding site (Figure 1. 5A). The 
Rossmann-like fold core is formed from discontinuous regions of the polypeptide chain and space 
residues Ser11 through Asp217, Pro255 through Ala287, and Pro354 through the carboxy-
terminus. This core consists of a seven-stranded β-sheet core that is sandwiched between sets of 
helical regions. The helical capping domain is similarly composed of disjointed segments and 
forms part of the active site, in a fashion similar to that found in plant natural product 
methyltransferases [25, 26, 53].  
Despite a low conservation in primary sequence, a search of the Protein Data Bank [54] 
using the Dali server [55] shows that MmFAMT is structurally homologous to the SABATH class 
of plant natural product methyltransferases, which themselves are only distantly related to other 
well-characterized small molecule methyltransferases [27]. Representative structural homologs 
include the salicylic acid O-methyltransferase from Clarkia breweri (PDB code 1M6E; RMSD of 
2.5 Å over 330 Cα atoms; 23% sequence identity) [26], the dimethylxanthine N-methyltransferase 
from Coffea canephora (PDB code 2EFJ; RMSD of 3.2 Å over 328 Cα atoms; 22% sequence 
identity) [25], and indole-3-acetic acid O-methyltransferase from Arabidopsis thaliana (PDB code 
3B5I; RMSD of 2.6 Å over 312 Cα atoms; 23% sequence identity) [53] (Figure A. 3). The 
unexpected structural similarities between MmFAMT and the plant SABATH O-
methyltransferases reflect the similar substrate repertoires of these enzymes, specifically that they 
both catalyze methylation of carboxylic acid on an otherwise hydrophobic substrate. However, the 
nature of the hydrophobic groups differs as the plant enzymes utilize larger, bulkier scaffolds that 
are typically aromatic, while the FAMTs function on fatty acids containing a long hydrocarbon 
acyl chain (Figure 1. 1). 
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The plant SABATH methyltransferases described above are all homodimers in solution and 
the corresponding crystal structures demonstrate a two-fold symmetric arrangement, and 
MmFAMT likewise is homodimeric both in solution and in the crystal lattice (Figure A. 1). In 
plant O-methyltransferases that are not members of the SABATH class, notably chalcone O-
methyltransferase, and caffeic acid O-methyltransferase, the dimeric arrangement is functional 
with residues from one monomer contributing to the active site of the other subunit [56, 57]. 
Although the SABATH enzymes are also dimeric, oligomerization is not needed for activity. 
Oligomerization of MmFAMT is similarly likely not functional as the monomeric entity contains 
all of the necessary residues involved in catalysis. Likewise, dimerization only buries ~1,314 Å2 
of solvent-accessible surface area (corresponding to 8% of the total surface area of each monomer), 
which is far less than for the functionally homodimeric enzymes. The dimerization interface of 
MmFAMT is similar in organization to that of the salicylic acid O-methyltransferase [26] and 
indole-3-acetic acid O-methyltransferase [53], both of which also likely function as a monomer. 
 
SAM/SAH and Substrate Binding Pockets 
Like in other class I methyltransferases, the SAM/SAH binding site is situated in the 
Rossmann-like fold domain, and the ligand is bound in an extended manner, roughly perpendicular 
to the plane of the β-strands. In the MmFAMT-SAH structure, the pyrimidine ring of SAH adenine 
is sandwiched between the side chain of Phe134, via a π-stacking interaction, on one side and 
Val99 on the other (Figure 1. 5B). Extensive hydrogen-bonding interactions further stabilize the 
bound SAH, including the interaction between Ser133 and the adenine amine, between Asp98 and 
both hydroxyls of the ribose, and between Tyr24 and Ser150 and the α-carboxylate of SAH. 
Additional contacts are mediated through van der Waals interactions with non-polar residues that 
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contribute to form the SAM/SAH binding site. An analogous network of interacting residues 
stabilizes bound SAM/SAH in structures of the plant natural product O-methyltransferases. The 
extensive set of interactions and the hydrophobicity of the binding site rationalize why uncharged 
SAH is a strong competitive inhibitor of MmFAMT. 
The cocrystal structure of MmFAMT with SAH and octanoate shows that the substrate-
binding site is largely localized within the α-helical domain that caps the Rossmann-like fold 
domain (Figure A. 3). This capping domain contains a binding cavity that is sufficiently contoured 
to accommodate fatty acid substrates with acyl chain lengths up to C12. Numerous aliphatic and 
aromatic residues encircle the acyl chain of the fatty acid substrate and these include Trp155, 
Met214, Phe222, Tyr224, Val256, Phe311, and Leu316 (Figure 1. 6A). MmFAMT residues 
Tyr174, Met 227 and Asn228 enclose the upper side of the binding cavity, and multiple conformers 
are observed for the latter two residues. The planar, extended conformation of the fatty acid 
substrate is set by the side chains of Met19, Ala315, and Leu316 on one side of the substrate and 
by Trp151, and Tyr224 on the opposite side of the substrate. In the salicylic acid O-
methyltransferase cocrystal structure, Met150 and Met308 similarly sandwich the substrate for 
proper positioning at the SAM methyl donor [26]. Lastly, hydrogen bonding with Gln31 and 
Trp155 engage and orient the carboxylate moiety of the fatty acid substrate for methyl transfer, 
similar to the Gln25/Trp151 pair utilized by salicylic acid O-methyltransferase to orient the 
carboxylate of its substrate. The relative disposition of the α-helical capping and Rossmann-fold 
domains is slightly different than that observed in structures of plant O-methyltransferases with a 
similar bi-lobed structure, which may also contribute to different substrate scope of the FAMTs 
(Figure A. 3). 
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A comparison of the MmFAMT/SAH cocrystal structures with bound octanoate and 3-
hydroxydecanoate suggests a rationale for understanding why MmFAMT shows a preference for 
the larger substrate (KM values of C10 substrates lower by a factor of ~10-40 relative to the C8 
counterparts; Table 1. 1). While Met227 and Asn228 are observed as multiple conformers in the 
cocrystal structure with octanoate (Figure 1. 6B), both of these residues exist in single 
conformations oriented away from the substrate-binding cavity to accommodate the larger acyl 
chain in the SAH/3-hydroxydecanoate structure (Figure 1. 6D). This movement is accompanied 
by a compensatory reorganization of a loop spanning residues Leu166 through Gln171, located 
near the omega carbon of the fatty acid, resulting in tighter packing against C9 and C10 of the acyl 
chain (Figure 1. 6Figure 1.6D). Movement of these side chains fills the substrate-binding cavity 
but only with acyl chains of length C10-C12, and likely explains why these longer chain fatty acids 
are better substrates than octanoate (Figure 1. 6B and Figure 1. 6D). There are limited interactions 
in the active site with the 3-hydroxyl moiety, as Gln154 is located within hydrogen bonding 
distance and the thioether of Met214 is over 3.2 Å away. Placement of the polar 3-hydroxyalcohol 
in a hydrophobic binding pocket without sufficient compensatory interactions may explain the 
higher KM values for 3-hydroxy-containing substrates, relative to their acyl counterparts (Table 1. 
1). Lastly, Gln154 is positioned to hydrogen bond with the carboxylate of the substrate in the 
MmFAMT/SAH/octanoate structure. However, a modest rotation of the plane of the substrate, 
necessary to maximize interactions of the 3-hydroxyl group with Gln154, results in a slight 




In the cocrystal structure of MmFAMT with 3-hydroxydecanoate, only the S enantiomer 
was bound in the active site although an enantiomeric mixture of 50% R and 50% S was used in 
the crystallization condition. This enantiomeric selectivity is due to the presence of hydrophobic 
residues (Phe311 and Trp151) on one side of the active site in close proximity to the carboxyl 
Figure 1. 6: (A, C) Difference Fourier maps (Fo-Fc) contoured to 2.5σ (blue) showing the bound 
fatty acid substrates (colored in green). (B, D) Surface cut-away diagram showing that binding of 
the larger substrate results in a smaller cavity due to movement of Leu166 through Gln171. 
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group, and the presence of Gln154 on the other side in a position favorable for hydrogen bonding 
with the 3-hydroxyl group of the S enantiomer. Although the physiological role of MmFAMT is 
yet to be elucidated, this enantiomeric specificity may be of physiological relevance. 3-
hydroxylated fatty acids are found in mycobacterial phospholipids [58, 59], enter β-oxidation as 
(S)-3-hydroxy-acyl-Coenzyme A [60, 61], and are part of the mycolic acid biosynthesis as (R)-3-
hydroxy-acyl-ACP (Acyl Carrier Protein) [62, 63]. Methylation of the carboxyl group of the (S)-
3-hydroxy fatty acids may be part of any of these processes by regulating the fate of the (S)-3-
hydroxy-fatty acids. This hypothesis, however, is to be investigated. 
 
Molecular Basis for Fatty Acid Substrate Specificity 
As noted, the structure of MmFAMT shares several features with that of salicylic acid O-
methyltransferase [26], including the presence of a hydrophobic α-helical domain that caps the 
SAM-binding site. While both enzymes utilize a similar constellation of active site residues to 
orient the substrate carboxylate (Gln31/Trp155 in MmFAMT and Gln25/Trp151 in salicylic acid 
O-methyltransferase), the capping domain establishes specificity for the hydrophobic part of the 
substrate (Figure 1. 7A and Figure 1. 7B). Specifically, the contours of each cavity are optimized 
for its cognate substrate. In salicylic acid O-methyltransferase the active site is border lined by Ile 
225, Trp226, Tyr255 and Phe347, while in MmFAMT by Tyr174, Phe222, Tyr224, Met227 and 
Asn228. The replacement of Ile225 and Trp226 (in salicylic acid O-methyltransferase) by Met227 
and Asn228 (in MmFAMT) creates a larger cavity to accommodate the longer acyl chain of the 
fatty acid (Figure 1. 6, Figure 1. 7A, and Figure 1. 77B).  
Although the constrained smaller cavity of salicylic acid O-methyltransferase may not 
accommodate a fatty acid, the larger cavity of MmFAMT raised the question as to whether 
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MmFAMT can utilize salicylic acid (SA) as a substrate despite the lack of residues that would 
anchor the aromatic ring in an optimal orientation. In order to further investigate this, we carried 
out reactions (2 h incubation at 37 °C) of MmFAMT with SA in triplicate, and analyzed the 
Figure 1. 7: Comparison of the substrate binding active site in (A) MmFAMT and (B) the 
SABATH family enzyme salicylic acid O-methyltransferase. (C) Structure based alignment of the 
primary sequences of MmFAMT, MsXMT and salicylic acid O-methyltransferase. The green 
triangles demarcate residues involved in interactions with the carboxylic acid, the brown circles 
demarcate residues that form the fatty acid binding pocket, and the magenta diamonds indicate 
residues that interact with SAH/SAM. 
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products by gas chromatography-mass spectrometry (GC/MS). Surprisingly, MmFAMT is able to 
catalyze methylation on SA (Table A. 2). A closer examination of an active site superposition of 
the cocrystal structures of MmFAMT-SAH-octanoate and salicylic acid O-methyltransferase-
SAH-SA reveals that SA can be accommodated into the MmFAMT active site. Although the 
positioning of Phe311 (Cys307 in salicylic acid O-methyltransferase) would seemingly cause some 
steric clashes, the residue at the other side of the aromatic ring (Tyr255 in salicylic acid O-
methyltransferase) is a smaller Val256 in MmFAMT, which would allow for positioning of SA as 
a substrate. Equivalent, but distinct, residues in the MmFAMT active site could orient SA. 
However, in salicylic acid O-methyltransferase, Ile225 and Trp226, which are replaced by the 
aforementioned flexible Met 227-Asn228 in MmFAMT, constrict the upper end of the active site 
to accommodate the smaller SA substrate (Figure 1. 7A and Figure 1. 7B). Consequently, it is 
likely that SA may not bind very well in the MmFAMT active site. 
 
Kinetic Analysis of Wild Type and Mutants MmFAMTs  
The cocrystal structures of MmFAMT identified a number of residues that may play a role 
in either substrate binding or catalysis. In order to further probe function, we generated site-specific 
mutations at several of these residues, and determined kinetic parameters for the variant enzymes 
(Table 1. 1). The Gln31Ala mutation had an immense effect on the enzyme activity as no product 
formation could be detected even when 20-fold more enzyme and much greater concentrations (up 
to 5 mM) of substrate were used. Similarly, the Trp155Phe mutation resulted in a near 1000-
fold decrease in catalytic efficiency (kcat/KM). As Gln31 and Trp155 are situated near the 
carboxylate of the substrate, the Gln31Ala and Trp155Phe mutations likely compromise 
binding and orientation of the substrate, consistent with the loss of activity in each of these mutants.  
27 
 
The Gln154Ala mutation had a large effect on the KM of MmFAMT with octanoate as a 
substrate (17-fold increase) and a smaller effect on the KM for 3-hydroxydecanoate (5-fold 
increase). This was an unexpected result as Gln154 is within hydrogen bonding distance to the 3-
hydoxyl group, and a mutation at this residue would be expected to cause a much greater increase 
in the KM for the 3-hydroxy fatty acid. In order to provide a rationale for this observation, we 
determined the 1.85 Å resolution co-crystal structure of MmFAMT Gln154Ala in complex with 
SAH and 3-hydroxydecanoate. The structure shows that the 3-hydroxyl group rotates towards the 
sulfur of Met214 to compensate for the loss of interaction with Gln154 (Figure A. 2), explaining 
why this mutation results in only a modest increase in the KM for 3-hydroxydecanoate. The 
Gln154Ala mutation also results in the carboxylate shifting away to result in a less-optimal 
orientation for methyl transfer, consistent with a 10-fold lower kcat for the mutant relative to wild-
type MmFAMT. 
 
1.4 Concluding Remarks  
Our collective structural and biochemical analysis demonstrates how MmFAMT uses a 
SABATH plant natural product methyltransferase architecture to catalyze the methylation of fatty 
acid substrates. This adaptation is a result of minor alterations in secondary structural elements, 
and of the changes in the disposition of the α-helical capping domain, which engages the substrate, 
relative to the Rossmann-like fold domain that harbors the methyl donor. Nonetheless, the 
identification of MmFAMT as a structural homolog of the SABATH class of methyltransferases 
extends the function of Pfam03492 [27] to beyond plant metabolism. 
Prior studies on the plant SABATH members suggest that these enzymes do not require a 
general base to deprotonate the substrate methyl acceptor, as its carboxylate is likely ionized at 
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physiological pH due to its low pKa [26]. Likewise, there are no residues in the active site of 
MmFAMT that can abstract the proton from the fatty acid carboxylate prior to methyl transfer, 
suggesting that the enzyme active site simply serves to facilitate proximity and orientation of the 
reactive groups. The side chain amide of Gln31 and the indole nitrogen of Trp155 are within 
hydrogen bonding distance from the two carboxylate oxygens, and structure-guided engineering 
studies [26] demonstrate that replacement of the equivalent Gln in plant O-methyltransferases 
establishes a selectivity against different methyl acceptors. The replacement of both of these 
residues in the MmFAMT homolog from Mycobacterium smegmatis (52% sequence identity, 
UniProt ID: A0R0D4) (MsXMT in Figure 1. 7C) may account for the lack of activity against fatty 
acid substrates in the latter [9].  
Studies of plant SABATH enzymes have determined that small changes in the primary 
amino acid sequence of these enzymes can establish methyltransferase activity on structural 
scaffolds with diverse chemical structures. Similarly, small changes in the primary sequence of 
mycobacterial methyltransferases homologous to MmFAMT (Figure 1. 8 and Figure A. 4) provide 
a pool of enzymes that have been engineered by nature to utilize fatty acids of different chain 
lengths. The identification of the active site residues of MmFAMT that recognize the carboxyl of 
the substrate as well as the residues that line the hydrophobic pocket that harbors the fatty acid tail 
can guide the selection of MmFAMT homologs for the in vivo production of various fatty acid 
methyl esters of desired length.  
Prior attempts to utilize MmFAMT for production of biodiesel in E.coli [9] resulted in yields 
that were considerably lower than other reported fatty acid ethyl esterification processes [7]. From 
the crystal structure of MmFAMT, as well as the previous in vivo studies [9], it is evident that 
MmFAMT can methylate medium chain fatty acids (up to 12-14 carbons long), which could 
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account for the low observed yields. Specifically, low compatibility between MmFAMT and the 
fatty acid thioesterases used to generate the fatty acid substrate would result in methylation of only 
a fraction of the available fatty acids. The utilization of complementary combinations of 
thioesterases with mycobacterial methyltransferases that accept different fatty acid substrate 
Figure 1. 8: Sequence similarity network. The network contains 838 nodes and 242,549 edges. 
Each node represents amino acid sequences that are 95% or more identical, and each edge connects 
a pair of sequences at an E-value of better than 1x10-30. This E-value is the one generated by the 
EFI-EST, and is not identical to E-values generated by BLAST. Teal: plants, indigo: 
actinobacteria, fuchsia: proteobacteria, green: cyanobacteria, red: fungi, plum: other. 
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lengths can result in better yields. Based on our results, additional metabolic engineering, for 
example overexpression of an efficient SAH nucleosidase to avert product inhibition by SAH, can 
further increase the methyl ester production. These data provide a starting point for engineering 
efforts directed at exploiting both MmFAMT and homologs for the in vivo production of various 
fatty acid methyl esters of desired length. 
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CHAPTER 2: STRUCTURAL STUDIES OF THE WAX 
ESTER SYNTHASE FROM Marinobacter aquaeolei VT8 
2.1 Introduction  
Wax esters have widely been used in the cosmetics, lubricant, candle, and food industries 
since the 19th century [1]. Up until the 1960s, the main source of wax esters was oil from sperm 
whales, until their endangerment resulted in a global ban on whaling [2]. Since the Endangered 
Species Act in 1973 and the ban on sperm oil use, alternative sources of wax esters have been 
sought. Currently, wax esters are extracted from plants (e.g. jojoba oil) or are chemically 
synthesized from expensive precursors [3, 4]. Hence, there is a strong demand for the development 
of large-scale processes for the production of low cost wax esters. Towards that end, there has 
been increasing focus in the development of methods for the enzymatic biosynthesis of wax esters. 
Current methods center on the use of enzymes immobilized on solid supports, as well as the use 
of cellular ‘factories’ engineered to produce the desired wax esters [4-8]. 
Wax esters are esters of long chain fatty acids and long chain alcohols that are formed in 
vivo by the condensation of a fatty alcohol and a fatty acyl-Coenzyme A (acyl-CoA), a reaction 
catalyzed by acyltransferases termed wax ester synthases (WS, EC 2.3.1.75). These 
acyltransferases are largely found in bacteria, plants and animals, and can also catalyze the 
transesterification of acyl-CoAs with diacylglycerols (DAGs), an activity known as diacylglycerol 
O-acyltransferase (DGAT, EC 2.3.1.20) [9-13]. In bacteria, all the WSs that have been 
characterized thus far are bifunctional, and encode both WS and DGAT activities [13, 14]. 
Although a few bifunctional WS/DGATs from plants and marine protists have been characterized, 
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there is dearth in information about the large number of predicted WS/DGAT sequences in 
eukaryotic genomes that have yet to be experimentally validated [14-18]. 
Bacterial WS/DGATs are presumptively promiscuous enzymes as homologs from different 
species show preference for different acyl chain length and/or degree of saturation [19-21]. This 
promiscuity has been exploited in the biotechnological utilization of different WS/DGAT 
homologs for the in vivo production of wax esters and biodiesel (esters consisting of medium chain 
fatty acids and ethanol) [5, 8, 22, 23]. Currently, the most well studied WS/DGATs are those from 
Acinetobacter baylyi ADP1 (Ab-WS/DGAT) and Marinobacter aquaeolei VT8 (Ma-WS/DGAT) 
[12, 14, 19, 20, 24, 25]. These enzymes have been utilized for the in vivo production of biodiesel 
and other wax esters by several laboratories, and engineering efforts to alter their substrate 
specificity have been an area of significant focus [21, 24, 26-32]. There is currently no structure 
available for any member of this enzyme family in the Protein Data Bank (PDB), which limits 
engineering efforts aimed at altering substrate scope for a given WS/DGAT.  
Bacterial WS/DGATs share low overall sequence similarity not only with eukaryotic 
WS/DGATs, but also with other bacterial homologs, both across and within species [13, 14]. 
Despite the overall low sequence similarity, all WS/DGATs share a conserved HHXXXDG motif, 
which is also found in other acyltransferases, such as the condensation domains of non-ribosomal 
peptide synthases, chloramphenicol acetyltransferase, and polyketide-associated proteins (Pap) 
from Mycobacteria [33, 34]. In each of these acyltransferases, the conserved motif contains a 
catalytic His that has been proposed to act as the general base that abstracts a proton from the 
alcoholic substrate hydroxyl to generate a nucleophilic alkoxide (Figure 2. 1) [33-36]. Attack of 
the alkoxide onto the carbonyl carbon of the acyl-CoA thioester produces a tetrahedral 
intermediate, which subsequently collapses to yield the acylated alcohol and free CoA. In the case 
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of chloramphenicol acetyltransferase and PapA5 from Mycobacterium tuberculosis, the second 
His in the HHXXXDG motif is proposed to be the general base [34-36]. However, in bacterial 
WS/DGATs, the identity of the catalytic His has yet to be established. In vitro studies and 
mutational analyses performed with WS/DGATs from Acinetobacter baylyi ADP1 and 
Marinobacter aquaeolei VT8 showed that mutation of either of the two His severely affected the 
activity of the enzyme, suggesting that both are important for catalysis [13, 14]. Mutation of the 
conserved Asp in this motif, decreased, but did not abolish the activity of the enzyme suggesting 
a structural, rather than catalytic role [14, 37]. 
Here, we report the first crystal structure of any WS/DGAT, that from Marinobacter 
aquaeolei VT8 (Ma-WS/DGAT, homolog WS1, UniProt accession number A1TX06). The 
structural data in conjunction with structure-guided mutational analysis allowed assignment of the 
roles for residues in the conserved HHXXXDG motif, and provide a molecular framework for 
identifying the binding sites for each of the two substrates. We also utilized the structure to guide 
engineering experiments aimed at altering the substrate scope of the enzyme. Our studies 
demonstrate that structure-guided engineering may be an expedient route for producing 
Figure 2. 1: Proposed mechanism of bacterial WS/DGAT. A catalytic histidine of the conserved 
motif HHXXXDG abstracts a proton from the hydroxyl moiety of the substrate generating an 
alkoxide ion. This alkoxide ion subsequently attacks the carbonyl carbon of the thioester bond in 
acyl-CoA resulting in a tetrahedral intermediate which collapses resulting in the acylated product 
and free CoA. Abbreviations: DAG for diacylglycerol and CoA for Coenzyme A. 
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WS/DGAT variants with different product profiles, which is an area of immense interest in 
biotechnology. 
 
2.2 Materials and Methods 
Chemical and Reagents  
All chemical reagents were purchased from Sigma-Aldrich unless otherwise noted. All of 
the material used for protein production and purification were purchased from GE Healthcare.  
 
Cloning and Site-Specific Mutagenesis  
Ma-WS/DGAT (GenBank accession number WP_011783747 – locus NC_008740.1) was 
amplified using the PCR with template genomic DNA of Marinobacter aquaeolei VT8 (DSM 
11845) and primers designed based on the published sequence. The gene was inserted into the pET 
His6-Sumo-TEV LIC cloning vector (2S-T) (Addgene plasmid # 29711), and this plasmid was 
used as template for the generation of the site-specific mutants by PCR (primers shown in Table 
2. 1). Sanger sequencing was used to confirm the integrity of all recombinant plasmids (ACGT, 
Inc.).  
 
Protein Expression and Purification  
Expression vectors bearing wild type or mutant Ma-WS/DGAT were transformed into E. 
coli Rosetta 2(DE3) cells for heterologous protein production. A 4 ml fresh starter culture was 
inoculated in 1 L Luria-Bertani growth medium supplemented with 100 µg/mL ampicillin and 25 
µg/mL chloramphenicol. The culture was grown at 37 °C until the absorbance at 600 nm reached 
0.6 – 0.8, at which point protein production was induced by addition of 0.3 mM isopropyl β-D-1-
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thiogalactopyranoside (IPTG). The culture was then cooled to 18 °C and grown with shaking for 
an additional 18 h. Cells were collected by centrifugation, resuspended in Buffer A (20 mM Tris-
HCl, pH 8.0, 500 mM NaCl, 10% glycerol), and lysed by multiple passages through a C5 
Emulsiflex (Avestin) cell homogenizer. Following centrifugation of the lysate, the supernatant was 
applied to a 5 mL His-Trap (GE Biosciences) column that was previously equilibrated with Buffer 
B (20 mM Tris-HCl, pH 8.0, 1 M NaCl, 30 mM imidazole, 10% glycerol). The column was washed 
with 20 mL of buffer B, 20 mL of buffer B supplemented with 5 mM MgCl2 and 5 mM ATP, and 
15 mL of buffer C (20 mM Tris-HCl, pH 8.0, 1M NaCl, 50 mM imidazole, 10% glycerol). Elution 
of the bound, His6-SUMO-tagged protein was carried out using a gradient of increasing imidazole 
concentration (to a final concentration of 200 mM). Fractions containing protein of the highest 
purity (as determined by sodium dodecyl sulphate - polyacrylamide electrophoresis, SDS-PAGE) 
Table 2. 1: Primers used for amplification of wild type Ma-WS/DGAT and generation of mutants.
 
Primer name Sequence (5'-3') 
MnWS/DGAT_F TACTTCCAATCCAATGCA ATGACGCCCCTGAATCCCACTG 
MnWS/DGAT_R TTATCCACTTCCAATGTTATTATTACAGACCGGCGTTGAGCTCC 













were pooled, and the His6-SUMO-tag was removed by overnight incubation with tobacco etch 
viral protease, followed by dialysis against Buffer D (20 mM Tris-HCl, pH 8.0, 1 M NaCl, 1mM 
DTT, 10% glycerol) at 4 °C. The dialyzed samples were re-applied to a 5 ml His-Trap (GE 
Biosciences) column to remove the His6-SUMO-tag, and pure fractions of the tag-excised protein 
were further purified using size exclusion chromatography (SEC) (Superdex Hiload 200 16/60) in 
a buffer of 20 mM Tris-HCl, pH 8.0, 1 M NaCl. Samples were concentrated using a 10,000 Da 
molecular weight cutoff Amicon centrifugal filters. Selenomethionine-labeled (SeMet) Ma-
WS/DGAT was produced by repression of methionine biosynthesis in defined media prior to 
protein induction, and was purified as described above. All proteins were flash frozen in liquid 
nitrogen and stored at -80 °C.  
For activity studies, Ma-WS/DGAT wild type and mutants were purified as described above 
with the following modification: After cleavage of the His6-SUMO-tag and the second His-affinity 
column, all samples were passed through a PD-10 desalting column (GE Healthcare), instead of 
SEC, for buffer exchange (20 mM Tris-HCl, pH 8.0, 1 M NaCl). The purity of all samples was 
assessed by SDS - PAGE analysis (Figure S1), and protein concentrations were determined by 
NanoDrop (Thermo Fisher Scientific) analyses using the molecular weights and extinction 







Initial crystallization conditions were determined by the sparse matrix sampling method 
using commercial screens. Crystals of Ma-WS/DGAT were grown using the hanging vapor drop 
diffusion method. Briefly, 1 μl of protein at 4 mg/ml concentration was incubated with 1.2 molar 
equivalents of palmitoyl-CoA (C16-CoA), mixed with 2 μl of precipitant solution (0.2 M L-Pro, 
0.1 M MES, pH 7.0, 8% PEG 3350), and equilibrated over a well containing the same precipitant 
solution at 9 °C. Crystals took 1 month to grow, and were used to seed subsequent optimization 
trays. After several rounds of optimization and seeding, diffraction-quality crystals were obtained 
at 6 mg/ml protein concentration in 0.2 M L-Pro, 0.1 M MES, pH 7.0, 12% PEG 3350 at 16 °C. 
The crystals were sequentially soaked in precipitant solution supplemented with increasing 
concentrations of 10, 20 and 30% ethylene glycol prior to vitrification by direct immersion in 
liquid nitrogen. SeMet crystals were grown by seeding with seeds from native crystals at 2 mg/ml 
protein concentration in 0.2 M L-Pro, 0.1 M MES, pH 7.0, 12% PEG 3350 at 16 °C. Attempts to 
Ma-WS/DGAT 
variant 
ε280 (M-1cm-1) x 103 MW (kDa) 
WT 61.88 51.75 
D8A 61.88 51.70 
G25V 61.88 51.79 
H136N 61.88 51.72 
D140A 61.88 51.70 
A144V 61.88 51.77 
A144F 61.88 51.83 
 
Table 2. 2: Extinction coefficients and molecular weights as calculated by ProtParam (ExPASY 




soak the crystals with palmitoyl-CoA (C16-CoA), hexanoyl-CoA (C6-CoA), CoA and hexanol 
(C6-OH) were not successful. 
 
 Data Collection, Phasing and Structure Determination  
X-ray diffraction data were collected at Life Sciences Collaborative Access Team (LS-
CAT), Sector 21, Argonne National Laboratory. All data were indexed, integrated and scaled using 
either HKL2000 or AutoProc [39-42]. Initial crystallographic phases were determined using single 
wavelength anomalous diffraction data collected from crystals of SeMet-labeled Ma-WS/DGAT 
at the Se absorption edge (λ=0.97872 Å) to a diffraction limit of 2.9 Å. Heavy atom sites were 
located using the Hybrid Substructure Search submodule of the Phenix program suite [43-45], and 
were subsequently imported into the AutoSol wizard of Phenix for maximum likelihood phasing 
[46], yielding an initial figure of merit of 0.369.  A partial model of the structure was generated 
using automated methods as implemented in RESOLVE, and this initial model was further 
extended using the Phenix Autobuild wizard [47]. The resultant model was used as search probe 
for the determination of the native crystal structure by molecular replacement as implemented in 
the Phenix program suite [45]. The resultant solutions were subsequently used as starting models 
for several rounds of automated model building using Phenix Autobuild and Buccaneer [47-50], 
followed by rounds of manual rebuilding using Coot [51], and refinement using either Phenix 
Refine or REFMAC5 [52, 53]. Water molecules were added during refinement with Phenix Refine, 
and confirmed by manual inspection. In all cases, the quality of the in-progress model was 
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routinely monitored using both the free R factor and MolProbity for quality assurance [45, 54]. All 
crystallographic data collection and refinement statistics are provided in Table 2. 3. 
Table 2. 3: Data collection, phasing and refinement statistics (1. Highest resolution shell is shown 
in parenthesis, 2. Rsym = Ʃ |(Ii - <Ii>| Ʃ Ii where Ii = intensity of the ith reflection and <Ii> = mean 
intensity, 3. Mean figure of merit, 4. R-factor = Ʃ (|Fobs|-k|Fcalc|)/Ʃ |Fobs| and R-free is the R value 
for a test set of reflections consisting of a random 5% of the diffraction data not used in 
refinement). 
   SeMet Ma-WS/DGAT Native Ma-WS/DGAT 
Data collection   
Space Group P21 P21 
 a, b, c (Å), β (°) 69.4, 103.7, 69.9, 104.1 69.3, 103.9, 69.5, 103.5 
Resolution (Å) 103.7-2.9 103.9-2.4 
Rsym (%)[1, 2] 14.9 (82.7) 6.4 (73) 
I/σ(I) 13.1 (3.2) 23.4 (3.3) 
Completeness (%) 100 (100) 100 (99.9) 
Redundancy 9.7 (9.9) 10.8 (10.9) 
Total reflections 195,392 391,121 
Unique reflections 20,209 36,232 
   
Phasing   




Resolution (Å)  51.9-2.4 
No. reflections used  36,196 
Rwork / Rfree[4]  0.21/0.28 
 
  
Number of atoms 
Protein  6425 




Protein  64.60 




Bond lengths (Å)  0.008 
Bond angles (°)  0.992 
   
MOLPROBITY statistics   
Clash score  6.30 
Ramachandran outliers/ 
allowed/ favored (%) 




Wax Ester Synthase Activity Assay  
The wax ester synthase (WES) activity of the wild type enzyme and mutants was 
investigated by gas chromatography-mass spectroscopy (GC/MS). 200 μl reactions containing 
5.0 μM Ma-WS/DGAT, 50 μM palmitoyl-CoA (C16-CoA) or 100 μM hexanoyl-CoA (C6-CoA) 
and 1 mM 1-hexanol (C6-OH) were incubated at 30 °C for 0.5 h and stopped by addition of 200 
μL chloroform. They were subsequently vortexed and span down, and the chloroform phase was 
extracted and analyzed by GC/MS by the Roy J. Carver Biotechnology Center (University of 
Illinois at Urbana-Champaign). All reactions were performed in 50 mM NaPi, pH 7.5, 300 mM 
NaCl and 1.45% (final concentration) dimethyl sulfoxide (DMSO). The activity of the mutants 
was expressed as percentage of WE formation in respect to the wild type reaction (considered as 
100%). For this purpose, the area under the WE peak of the wild type reaction was considered as 
100%, and the areas under the WE peak of the mutants were converted to % of activity with the 
following equation: % of activity = (peak area of mutant) x 100 / (peak area of wild type). Control 
reactions without addition of the enzyme were also analyzed. Results are means of duplicate 
experiments.   
For the competition assay, reactions were prepared as described above with the following 
modification: 50 μM C16-CoA and 50 μM C6-CoA were both added in the reactions and the 
reactions were initiated by addition of 1 mM hexanol. The sum of the areas under the peaks for 
hexyl-palmitate and hexyl-caproate was considered as the total amount of wax esters produced 
(100%) and the relative abundance of each peak is reported as % of hexyl-palmitate and % of 





Diacylglycerol Acyltransferase Activity 
The diacylglycerol acyltransferase (DGAT) activity of the wild type enzyme was 
investigated by liquid chromatography-mass spectroscopy (LC/MS). 200 μl reactions containing 
5.0 μM Ma-WS/DGAT, 50 μM palmitoyl-CoA (C16-CoA) and 200 μM 1,2-dipalmitoyl-sn-
glycerol were incubated at 30 °C for 1 h and stopped by addition of 200 μL chloroform. They were 
subsequently vortexed and span down, and 150 μL of the chloroform phase were extracted, 
evaporated, resuspended in 20 μL chloroform and analyzed by LC/MS by the Roy J. Carver 
Biotechnology Center (University of Illinois at Urbana-Champaign). All reactions were performed 
in 50 mM NaPi, pH 7.0, 300 mM NaCl and 1.45% (final concentration) dimethyl sulfoxide 
(DMSO).  
 
Gas Chromatography-Mass Spectrometry (GC/MS) 
The samples were analyzed in the Metabolomics Laboratory of Roy J. Carver Biotechnology 
Center, University of Illinois at Urbana-Champaign, using a GC/MS system (Agilent Inc, CA, 
USA) consisting of an Agilent 7890 gas chromatograph, an Agilent 5975 MSD and an Agilent 
7683B autosampler. Gas chromatography was performed on a ZB-1MS (30mm×0.32mm I.D. and 
0.25μm film thickness) capillary column (Phenomenex, CA, USA).  The inlet and MS interface 
temperatures were set to 2800 °C., and the ion source temperature was adjusted to 230 °C. An 
aliquot of 1 μL was injected in a splitless mode (purge time 0.5 min). The helium carrier gas was 
kept at a constant flow rate of 2.3 mL/min. The temperature program was: 2 min isothermal heating 
at 180 °C, followed by an oven temperature increase of 15 °C min-1 to 330 °C and a final 10 min 
at 330 °C. The mass spectrometer was operated in positive electron impact mode (EI) at 69.9 eV 
ionization energy at m/z 33-500 range. Mass spectra were recorded in the combined scan/SIM 
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mode. For SIM mode m/z 340, 257 (hexyl-palmitate) and 117 (hexyl-caproate) were tracked.  
Hexyl-caproate was confirmed with NIST08 commercial database (NIST, MD, USA) while hexyl-
palmitate was confirmed by high resolution GC/MS. The mass spectrum of target compound was 
evaluated using the MSD Chemstation E.02.01.1177 software (Agilent, Palo Alto, CA, USA). 
 
Liquid Chromatography-Mass Spectrometry (LC/MS) 
The sample was analyzed by Q-Exactive MS system (Thermo.  Bremen, Germany) in the 
Metabolomics Laboratory of Roy J. Carver Biotechnology Center, University of Illinois at Urbana-
Champaign.  Software Xcalibur 4.1.31.9 was used for data acquisition and analysis.   Mass 
spectrum was acquired under positive ESI with the following settings: sheath gas flow rate, 49; 
aux gas flow rate: 12; sweep gas flow rate, 2; spray voltage, 3.5 kV; capillary temp,  259 °C; Aux 
gas heater temp, 419 °C.  The resolution was set to 70,000.  The AGC target was 1E6 with a 
maximum injection time of 50 ms. 
 
Amino Acid Residues Conservation Analysis 
The conservation of amino acids in Ma-WS/DGAT was analyzed by utilizing the ConSurf 
server [55, 56], a bioinformatics tool that analyzes the conservation of amino acids in a protein 
taking into account the evolutionary relationships between homologs of the same family. The 
homologs were collected from UNIREF90 using PSI-BLAST as the search algorithm. The settings 
were as follows: 90% maximum identity between sequences, 35% minimum identity between 
sequences, total of 500 closest sequences. The retrieved sequences were aligned using ClustalW, 
and a Bayesian method was used for the calculation of the conservation scores. There were 419 




A sequence logo was generated by WebLogo (http://weblogo.berkeley.edu/) [57, 58] using 
as input the curated seed alignment of PFAM for wax synthases (PFAM family PF03007) [59]. 
The numbering of the residues corresponds to the sequence of Ma-WS/DGAT. 
 
2.3 Results and Discussion 
Ma-WS/DGAT activity 
The WS/DGAT from Marinobacter aquaeolei VT8 (Ma-WS/DGAT) studied here has 
already been studied in terms of alcohol substrate promiscuity [20, 21]. However, before moving 
forward to structural studies, we confirmed the WS and DGAT activities of the enzyme using 
recombinant purified Ma-WS/DGAT. The enzyme was able to produce hexyl-palmitate and 
tripalmitate when palmitoyl-CoA and hexanol or 1,2-sn-dipalmitate were provided respectively 
(Figure 2. 2). 
 
Crystal Structure of Ma-WS/DGAT 
Ma-WS/DGAT was crystallized as a dimer at 2.4 Å in space group P21 showing a structure 
consisting of an N-terminal and C-terminal domains, connected via a helical linker (Figure 2. 3A). 
The N-terminal domain is composed of a mixed β-sheet (strands β1, β4, β5, β6, β11) flanked by 4 
α-helices (helices α1-α4), and a small antiparallel β-sheet (strands β2 and β3). The C-terminal 
domain consists of a mixed β-sheet (strands β7-β10 and β12-β13) that on one side is covered by 4 
α-helices (α6, α7, α8, α10), and on the other side it faces helix α9 and the N-terminal domain. The 
two domains are connected by helix α5 (residues 200-214). Disordered regions with poor electron 
density were built with caution, however, there are still small regions of unassigned density. The 
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final model is missing residues 169-198, 219-225, 296-308 and 341-348 from chain A, and 
residues 169-190, 217-225 and 296-308 from chain B. This high degree of disorder and flexibility 
may provide one reason why the crystals took long to grow (about one month). 
The crystal structure reveals the presence of a long cavity that is formed at the core of the 
N-terminal domain (pocket 1) and extends to the interface of the two domains (pocket 2) (Figure 
2. 3B). The conserved HHXXXDG motif is located on a loop that links strand β6 with helix α4 
Figure 2. 2: (A) GC/MS chromatogram of hexyl-palmitate. (B) Fragmentation pattern of peak at 
8.4 min. Only the high-resolution masses of the peaks corresponding to hexyl-palmitate and its 
fragments are shown. (C) High-resolution mass spectrum confirms target compound (tripalmitate) 
in the form of [M +NH4]+  (m/z = 824.76740).  Such NH4+ adduct is very common for tripalmitate.
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with His136 positioned to face towards pocket 2, while His135 is directed away from this cavity 
(Figure 2. 3A-C). Based on the orientation of the two conserved His, it is likely that His136 is 
catalytic while His135 plays a structural role. This notion is further supported by the fact that 
His135 is within hydrogen bonding distance from the highly conserved Glu15, the side chain of 
Ser137 and the amide nitrogens of His136 and Ser137 (Figure 2. 3C). Disruption of these 
interactions would explain why, in prior studies, enzyme activity was severely affected when the 
first His was substituted by Leu in the WS/DGAT from Acinetobacter baylyi ADP1 or by Ala in 
a different WS/DGAT homolog from Marinobacter aquaeolei VT8 (WS2, UniProt accession 
number A1U572) [13, 14]. In addition to His135, the crystal structure suggests that Asp140 also 
play a structural role. The side chain of Asp140 is involved in hydrogen bonding interactions with 
the first three residues of helix α4 (Figure 2. 3D). Presumably, disruption of these interactions 
would affect the structural integrity of the loop where the catalytic His135 is located and would 
account for the significant loss of activity when by an Ala substitution at this conserved Asp [14, 
37]. 
In one of the two chains in the non-crystallographic dimer, there is unassigned electron 
density adjacent to His136. Attempts to fit glycerol, MES and PEG were not successful as these 
ligands were too small to justify the observed density. It is possible that some other ligand co-








Figure 2. 3: (A) Ribbon diagram of the overall structure of Ma-WS/DGAT (one monomer shown). 
The N-terminal domain is shown in purple, the C-terminal domain in gray and the helical linker in 
yellow. (B) The cavity of Ma-WS/DGAT is shown in black, and the conserved motif HHXXXDG 
(HHSLVDG in Ma-WS/DGAT) is colored in yellow. For description purposes, the cavity is 
divided into pocket 1 and pocket 2. (C) His135 points away from the enzyme cavity, and is in 
hydrogen bonding distance from Glu15, His136 and Ser137. All 4 residues are highly conserved. 
(D) Asp140 seems to play structural role forming interactions mainly with the peptide backbone. 
Distances shown are in Å. 
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Amino Acid Residues Conservation 
The evolutionary conservation of amino acids across WS/DGATs was calculated and 
mapped onto the crystal structure of Ma-WS/DGAT. This amino acid conservation can provide 
useful information about functionally important residues, especially in protein families like the 
WS/DGAT that include homologs which share a low overall sequence similarity. In total, 396 
sequences with sequence identity of 35-90% to Ma-WS/DGAT were aligned, and the conservation 
score as calculated by ConSurf server [55, 56] was mapped on the crystal structure of Ma-
WS/DGAT (Figure 2. 4). Most of the highly conserved residues are located on regions that are 
important for the structural integrity of the enzyme. In addition to the conserved motif, only a few 
highly conserved residues line the enzyme cavity. These residues are located in a “ring” (Figure 
2) around where the catalysis is expected to take place and may be involved in orienting the 
substrates and stabilizing the tetrahedral intermediate. This low conservation of the cavity lining 
amino acid residues could justify the differences in substrate specificities between different 
Figure 2. 4: Amino acid sequence conservation mapped onto the structure of Ma-WS/DGAT (as 




homologs and could be exploited for structure-based engineering of Ma-WS/DGAT towards the 
design of variants with different substrate specificities. 
 
Substrate Binding Pockets 
The orientation of the conserved motif HHXXXDG suggests that the fatty alcohol or DAG 
substrates bind either in pocket 1 or pocket 2. Structural comparison of Ma-WS/DGAT with other 
acyltransferases, such as the TRI3 trichothecene 15-O-acetyltransferase from Fusarium 
sporotrichioides (FsTRI3) (PDB ID 3FP0, Z-score 18.9 and RMSD 4.6 Å as calculated by the Dali 
server) (Figure 2. 6A) [60, 61], suggests that the acyl acceptor substrates bind in pocket 2. This is 
in agreement with mutational studies where mutations at residues that reside in pocket 2 altered 
the alcohol substrate specificity of Ma-WS/DGAT [24]. In these studies, substitutions at Leu356 
and Met405 with either larger or smaller hydrophobic residues resulted in Ma-WS/DGAT variants 
with different selectivity towards small, branched and aromatic alcohols. It is notable that both 




residues are not highly conserved; in nature, there are WS/DGAT homologs that have several 
different amino acids in these positions (4-5 conservation score in the scale of ConSurf) [55]. 
Further structural comparison of Ma-WS/DGAT with other acyltransferases suggests that 
the phosphoadenosine moeity of acyl-CoA (Figure 2. 5) is exposed to the solvent and the 
pantetheine portion is extended into the active site with the thioester positioned close to His136 
and the acyl chain buried in pocket 1 (Figure 2. 6C). In this binding mode, the acyl chain is shielded 
from the solvent and the thioester is positioned next to the catalytic His136 and the acyl acceptor.  
Figure 2. 6: Ribbon diagram and cavity of: (A) TRI3 trichothecene 15-O-acetyltransferase from 
Fusarium sporotrichioides (FsTRI3) (PDB ID 3FP0).[61] The substrate (acetyl acceptor) is shown 
in sticks. (B) Hydroxycinnamoyl-CoA:shikimate hydroxycinnamoyltransferase from Arabidopsis 
thaliana (AtHCT) (PDB ID 5KJT).[62] The Coenzyme A (CoA) activated substrate (p-
coumaroyl-CoA) is shown in sticks. (C) Ma-WS/DGAT with palmitoyl-CoA modeled based on 
the superposition with AtHCT. The catalytic histidine residues are shown in sticks. (D, E, F) 
Comparison of the residues that line and constrict the pocket at the core of the N-terminal domains 
of FsTRI3, AtHCT and Ma-WS/DGAT respectively. 
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Since pocket 1 is about 24 Å long, Ma-WS/DGAT could accommodate acyl chains of 19-20 
carbons long if bound in a fully extended conformation. In comparison with other CoA dependent 
transferases that share the same fold, the pocket formed at the core of the N-terminal domain 
reflects the size and shape of the CoA activated substrate. In the active site of hydroxycinnamoyl-
CoA:shikimate hydroxycinnamoyltransferase from Arabidopsis thaliana (AtHCT) (PDB ID 
5KJT, Z-score 16.0 and RMSD 4.9 Å as calculated by the Dali server) [60, 62], p-coumaroyl-CoA 
is bound in a similar mode, and the size of the pocket is sufficient to accommodate the cognate 
ligand (Figure 2. 6B). Likewise, FsTRI3 acetyltransferase [61] lacks a pocket at the core of the N-
terminal domain as the substrate acetyl group is small and fits in the pocket formed at the interface 
of the two domains (Figure 2. 6A).  
Superposition of FsTRI3 and AtHCT with Ma-WS/DGAT reveals the molecular features 
that dictate the formation, size and shape of pocket 1. These features include shortening of strand 
β11 by introduction of a Pro residue at the C-terminal end of the strand, introduction of bulky 
hydrophobic residues such as Phe467 in FsTRI3 and Tyr40 in AtHCT to define the length of the 
binding pocket, and use of smaller hydrophobic residues such as Gly, Ala and Val to line the 
pocket of Ma-WS/DGAT (Figure 2. 6 D-F). In addition to these amino acid substitutions, the 
relative disposition of helix α4 and the β-sheet of the N-terminal domain is different among these 
acyltransferases and also results in the formation of differently sized binding pocket (Figure 2. 7). 
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To further investigate whether pocket 1 encompasses the acyl chain of palmitoyl-CoA, we 
generated site-specific variants and compared their activity with that of the wild type Ma-
WS/DGAT (Table 2. 4). We selected Gly25 and Ala144 to be mutated because of their position in 
pocket 1 and their average sequence conservation (Figure 2. 8A). Specifically, we generated 
Gly25Val and Ala144Val/Phe variants in an attempt to “shorten” pocket 1 so that acyl-CoAs 
more than 7 and 6 carbons long respectively do not “fit” if bound in a fully extended conformation. 
These variants were tested for activity using palmitoyl-CoA (C16-CoA) and their activities were 
compared against wild type (WT) Ma-WS/DGAT.  The Gly25Val mutation had an immense 
effect on the activity of the enzyme towards palmitoyl-CoA (1.0% of WT) while the 
Ala144Val/Phe variants were still ~ 40-50% active (Table 2. 4). Although, binding of palmitoyl-
CoA was not expected in the case of the Ala144Val/Phe mutants, these results suggest that 
Figure 2. 7: Superposition of WS/DGAT from Marinobacter aquaeolei VT8 (Ma-WS/DGAT) 
with (A) TRI3 trichothecene 15-O-acetyltransferase from Fusarium sporotrichioides (FsTRI3)2
and (B) hydroxycinnamoyl-CoA:shikimate hydroxycinnamoyltransferase from Arabidopsis 
thaliana (AtHCT)3. The figure shows the difference in the relative disposition of helix α4 and the 
β-sheet of the N-terminal domain in these acyltransferases. Ma-WS/DGAT is shown in blue, 
FsTRI3 in yellow and AtHCT in teal. The numbering of the secondary structure is based on the 
structure of Ma-WS/DGAT. 
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palmitoyl-CoA may still bind in a different, less favorable conformation where the acyl chain is 
folded instead of fully extended. This binding mode may energetically be even less favorable in 
the case of the Gly25Val mutant where pocket 1 is expected to be long enough to fit a 7-carbon 
long chain instead of 6.  In addition to palmitoyl-CoA, we tested the activity of the Gly25Val 
and Ala144Phe variants towards hexanoyl-CoA (C6-CoA). The Gly25Val variant was 46.9% 
active compared to WT Ma-WS/DGAT while a 5.5-fold increase in activity was observed for the 
Ala144Phe mutant (Table 2. 4). This increased activity of the mutants towards the shorter acyl-
CoA further supports the role of pocket 1 as the acyl chain-binding site. 
To compare the substrate preference of wild type, Gly25Val and Ala144Phe Ma-
WS/DGATs for acyl-CoA, we performed competition assays. Briefly, both hexanoyl- and 
palmitoyl-CoA were added in the reactions at equal concentrations, and the wax esters formed 
(hexyl-caproate and hexyl-palmitate respectively) were expressed as percentage of total wax esters 
Table 2. 4: Activity of wild type Ma-WS/DGAT and mutants. The activity of the mutants was 
expressed as percentage of WE formation in respect to the wild type reaction (considered as 100%). 
Results are means of duplicate experiments. (ND = Not Determined) 
Ma-WS/DGAT hexyl-palmitate (%) hexyl-caproate (%) 
WT 100 100 
H136N 1.5 ND 
D140A 49.6 ND 
D8A 24.1 ND 
G25V 1.0 46.9 
A144V 43.3 ND 
A144F 53 654.6 
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produced by the enzyme. Both mutants showed a preference for the shorter acyl-CoA with 
Gly25Val producing almost exclusively hexyl-caproate (~90% of total wax esters formed), and 
Ala144Phe producing ~65% hexyl-caproate and ~35% hexyl-palmitate (Figure 2. 9). Although 
the Gly25Val variant showed a clear preference for hexanoyl-CoA instead of palmitoyl-CoA, 
the Ala144Phe was more efficient as it produced more of both products. Nonetheless, these 
results further demonstrate that the acyl chain of the acyl-CoA binds in pocket 1 as well as that 






Figure 2. 8: Ribbon diagram and cavity of Ma-WS/DGAT colored based on amino acid 
conservation as calculated by ConSurf. (A) Gly25 and Ala144 are located on strand β1 and helix 
α4 respectively lining the cavity where the acyl chain binds. (B) Positioning of His136 for catalysis 
by the conserved motif loop (shown in sticks) and Phe11.  Asp8 is also involved in maintaining 
the structural integrity of the loop. Distances shown are in Å. 
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Role of Conserved Motif Residues 
The proposed mechanism for WS/DGATs requires abstraction of a proton from an alcohol 
by a His residue to generate the reactive alkoxide (Figure 2. 1). However, the side chain of His is 
not sufficiently nucleophilic to abstract a proton from an alcohol (pKa of about 17). This raises the 
question how the catalytic His can abstract hydroxyl proton from the acyl acceptor in the active 
site of WS/DGATs.  In the crystal structure of Ma-WS/DGAT, His136 is positioned for catalysis 
in two ways. First, the other residues of the conserved motif HHXXXDG (HHSLVDG in Ma-
WS/DGAT) form interactions that maintain the structural integrity of the loop and position His136 
towards the enzyme cavity (Figure 2. 3C-D). Second, the imidazole ring of His136 is oriented by 
π interactions with the aromatic ring of Phe11 (Figure 2. 8B). There are no residues, however, 
within hydrogen bonding distance from His136. The only other highly conserved residue adjacent 
Figure 2. 9: Percentage of total wax esters produced by Ma-WS/DGAT wild type (WT) and 
mutants when hexanol and both hexanoyl- and palmitoyl-CoA were added in the reactions. Results 
are means ± SEM of duplicate experiments. 
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to the catalytic His is Asp8 (Figure 2. 8B). This led us to the hypothesis that upon binding of the 
substrates, Asp8 might move closer to His136 and tune its pKa. To test this hypothesis, we 
generated an Asp8Ala mutant and found that its activity was about half of the wild type (Table 
2. 4). However, a closer examination of the structure revealed that it is hydrogen bonded to the 
carbonyl oxygen of Ser137 (Figure 2. 8B). This suggests that Asp8 may play a structural role in 
proper positioning of His136 for catalysis by participating in maintaining the structural integrity 
of the loop formed by the conserved motif. In the structure of AtHCT, the catalytic His153 is in 
hydrogen bonding distance from Asn300. Comparatively, the structure of Ma-WS/DGAT is 
missing residues 296-308 which include the highly conserved Asn306 and semi-conserved Glu307 
(Figure 2. 10). It is likely that these residues tune the pKa of His136 or that the environment of the 
active site makes His136 a stronger base for catalysis. 
 
 
2.4 Concluding Remarks  
Our structural analysis of Ma-WS/DGAT reveals an acyltransferase-like fold that has been 
adapted to accommodate large hydrophobic substrates. The structural data in conjunction with our 
mutational analysis suggest that the acyl chain of the acyl-CoA binds in a pocket formed at the 
Figure 2. 10: Sequence logo generated by WebLogo (http://weblogo.berkeley.edu/) using as input 
the curated seed alignment of PFAM for wax synthases (PF03007) [57-59]. Numbering of residues 
corresponds to the sequence of Ma-WS/DGAT. 
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core of the N-terminal domain. Notably, introduction in this pocket of the highly hydrophobic Phe 
at position 144 resulted in an enzyme that was 6.5 times more active towards a shorter acyl-CoA 
(C6-CoA) compared to the wild type. These results, in combination with previous studies [24], 
further support the notion that the bacterial WS/DGATs are amenable to site-directed engineering. 
This work provides a framework for further engineering studies aimed at in vivo production of 
desired wax esters utilizing bacterial WS/DGATs. 
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CHAPTER 3: STRUCTURE-FUNCTION STUDIES OF 
THE LOGANIC ACID O-METHYLTRANSFERASE 
FROM Catharanthus roseus2  
3.1 Introduction  
Monoterpenoid indole alkaloids (MIAs) are a group of plant natural products with a number 
of medicinal uses including chemotherapeutics (Vinca alkaloids), antihypertensives (ajmalicine 
and serpentine), and antidiabetics (vindolicine) [1-3]. These nitrogen-containing compounds are 
produced by the Mannich-type condensation of tryptamine with secologanin to yield strictosidine, 
which serves as the common intermediate for the ~3000 different MIAs of diverse chemical 
structures [4]. Currently, isolation of MIAs is dependent on direct extraction from plants, and the 
dispersion of the biosynthetic steps across different cells types, as well as the trace production 
levels in situ undermines cost-effective isolation of these molecules, and restricts detailed 
exploration of MIA pharmacognosy [5, 6]. The elucidation of the complete nine-step biosynthetic 
pathway for the production of secologanin from the primary metabolite geranyl pyrophosphate in 
the model plant Catharanthus roseus (Madagascar periwinkle) [7] has prompted efforts towards 
the heterologous production of the Vinca alkaloid vindoline [8], as well as the common precursor 
strictosidine in both Baker’s yeast (Saccharomyces cerevisiae) [9] and in a plant host (Nicotiana 
benthamiana) [7]. The last step in this seco-iridoid pathway involved the conversion of the 
                                                          
2 This chapter is adapted from the following published article: 
 
Nektaria Petronikolou, Allison Hollatz, Mary A. Schuler & Satish K. Nair (2018). Loganic Acid Methyltransferase: Insights into the specificity of 




cyclopentanopyran monoterpenoid glycoside loganic acid into loganin [10]. Loganin is an iridoid 
glycoside that itself has recently attracted interest as a drug candidate due to its reported 
neuroprotective properties, cognitive-inducing activity, and inhibitory effect on melanogenesis 
among other biological activities [11-15]. 
The conversion of loganic acid into loganin is catalyzed by loganic acid methyltransferase 
(LAMT), via the transfer of a methyl group from S-adenosyl-methionine (SAM) to the carboxylate 
of loganic acid (LA) [10, 16]. Random sequencing of C. roseus leaf epidermis-enriched cDNA 
library identified multiple genes encoding for putative SAM-dependent O-methyltransferases, and 
biochemical characterization of a heterologously expressed candidate LAMT from C. roseus 
(CraLAMT) confirmed its function as a loganic acid methyltransferase [10]. Bioinformatics 
analysis suggests that CraLAMT is a member of the SABATH family of methyltransferases [10], 
which include enzymes that modify small secondary metabolites such as plant hormones and 
signaling molecules. The biological activity of such plant metabolites is regulated by the addition 
or removal of the methyl group, implicating the network of SABATH enzymes in numerous 
processes that regulate plant responses to stress [17].  
In contrast to other characterized SABATH methyltransferases that demonstrate broad 
substrate tolerance [18], CraLAMT has been shown to be remarkably specific for only its 
physiological iridoid substrate [10]. Specifically, CraLAMT only methylates the glycosylated and 
hydroxylated iridoid ring ring rather than the aglycone (loganetic acid) or deoxyloganic acid [10, 
16]. The enzyme also demonstrates strict stereospecificity for loganic acid (6S,7R) as a substrate 
and fails to methylate either 7-epiloganic acid (6S,7S), or the oxidized 7-keto dehydrologanic acid. 
In addition to the strict substrate specificity, CrLAMT is further distinguished by the unique 
nature of its glycosylated substrate. Canonical plant SABATH methyltransferases function on 
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bulky hydrophobic compounds, such as salicylic acid, benzoic acid and indole-3-acetic acid. In 
contrast, the loganic acid substrate of CrLAMT contains a hydrophilic glucose moiety and several 
additional polar groups. In order to identify the molecular rationale for its unique substrate 
specificity that distinguishes it from canonical SABATH methyltransferases, we carried out 
biochemical characterizations and crystallographic structure determination of CrLAMT in 
complex with loganic acid, and mutational analyses of active site residues involved in catalysis. 
 
3.2 Materials and Methods  
Chemicals and Reagents 
All chemical reagents were purchased from Sigma-Aldrich unless otherwise noted. 
 
Cloning and Site-Specific Mutagenesis 
Coding sequences for the full-length loganic acid methyltransferase from Catharanthus 
roseus (CraLAMT) (Genbank EU057974) were initially reverse transcribed by PCR from 
Catharanthus roseus leaf RNA and inserted into the pGEM-T easy vector (Promega). Among 
several sequence variants obtained, the one identical to Genbank EU057974 was PCR-amplified 
with CraLAMT_WT_F and CraLAMT_WT_R (Table B. 1), and inserted into NcoI-XhoI cut 
pET28a (Invitrogen) in-frame with the C-terminal His6-tag in this expression vector. After 
confirmation of the full-length CraLAMT sequence, site-directed mutations were introduced using 
a PCR-based site-directed mutagenesis strategy with each reaction consisting of 25 ng of the His6-
tagged CraLAMT template in the pET28a cloning vector, 1.0 μM of each forward and reverse site-
directed mutagenesis primer (Table B. 1), 200 μM each dNTP, 2.5 units Pfu Ultra HF DNA 
polymerase (Agilent), 1X Pfu Ultra HF Buffer (Agilent), and molecular biology grade water 
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(Corning) to bring the total reaction volume to 25 μl. The reactions began with a 3 min denaturation 
step at 95 °C, proceeded with 17 cycles of 60 sec denaturation at 95 °C, 60 sec annealing at 36 - 
44 °C, 12 min extension at 68 °C and were followed with an 8 min extension at 68 °C and multiple 
hours at 4 °C. These PCR products were treated with 1 μl DpnI (Fermentas) in 1X CutSmart buffer 
(NEB) overnight at 37 °C to digest the original methylated His6-tagged CraLAMT template and 
the DpnI-digested PCR products were transformed into BL21 cells and screened by sequence 
analyses. All site-directed mutants were sequenced in their entirety to confirm the absence of other 
mutations.  
 
Protein Expression and Purification 
For protein expressions, all CraLAMT expression constructs were transformed into E. coli 
strain BL21 (Invitrogen) and inoculated into two 1.25 L cultures containing 50 μg/ml kanamycin. 
Cultures were incubated at 37 °C for 4 - 6 hours with shaking (180 rpm) until the OD600 readings 
reached 0.50 - 0.75, induced with 0.143 g/L IPTG and incubated at 25 °C for an additional 24 
hours. For protein purifications, cell pellets from the 2.5 L cultures were resuspended in 60 ml of 
Buffer A (50 mM NaPi - pH 8.0, 0.3 M NaCl, 10 mM imidazole), treated for one hour at 25 °C 
with 1 mg/ml lysozyme, sonicated at least three times for 15 sec and centrifuged at 17,000 rpm for 
30 min in a SS34 rotor (Sorvall). Each cleared supernatant was loaded onto a 10 ml Ni-NTA 
agarose affinity column (Qiagen) pre-equilibrated with Buffer A, washed with an additional 30 ml 
of Buffer A and 50 ml of Buffer B (50 mM NaPi - pH 8.0, 0.3 M NaCl, 50 mM imidazole). Bound 
proteins were eluted with 17 ml of Buffer C (50 mM NaPi - pH 8.0, 0.3 M NaCl, 250 mM 
imidazole), and dialyzed at 4 °C against four changes of 375 ml of Buffer D (50 mM Tris-HCl, pH 
7.5, 200 mM NaCl) (1.5 L total). Dialyzed protein samples were centrifuged for 1 min at 6000 rpm 
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in a clinical centrifuge to remove precipitated protein, adjusted to 10% glycerol and flash frozen 
in liquid nitrogen. No glycerol was added in the protein samples used for crystallization. Protein 
concentrations were determined by NanoDrop (Thermo Fisher Scientific) analyses using the 
molecular weights and extinction coefficients calculated by the ProtParam tool (ExPASY server) 
(Table B. 2) [19]. 
 
Crystallization 
Initial crystallization conditions were determined by the sparse matrix sampling method 
using commercial screens. Crystals of the CraLAMT-SAH (S-adenosyl-homocysteine) complex 
were grown using the sitting drop vapor diffusion method. Briefly, 1 μl of protein at 5 mg/ml 
concentration was incubated with 1 mM SAH (Sigma-Aldrich) for 30 min on ice, and was 
subsequently mixed with 1 μl of precipitant solution (20% PEG 6000, 0.1 M HEPES-NaOH, pH 
7.0, 0.2 M NaCl), and equilibrated with a well containing the precipitant solution at 9 °C. Crystals 
grew within few days, and were briefly soaked in precipitant solution supplemented with 30% 
ethylene glycol prior to flash-cooling in liquid nitrogen.  
Crystals of the CraLAMT-SAH-LA complex were grown using the hanging drop vapor 
diffusion method: 1 μl of protein at 5 mg/ml concentration was incubated with 4 mM LA (Sigma-
Aldrich) for 1 h at room temperature, and was subsequently mixed with 1 μl of precipitant solution 
(18% PEG 6000, 0.1 M MES-NaOH, pH 7.0, 0.2 M NaCl), and equilibrated over a well containing 
the precipitant solution at 9 °C. Once crystals were formed, they were transferred into a drop 
containing the precipitant solution and 4 mM LA for 1 h at 9 °C, and were subsequently transferred 
into a drop containing the precipitant solution, 4 mM LA and 2 mM SAH for 1 h at 9 °C. Crystals 
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were briefly soaked in precipitant solution supplemented with 30% ethylene glycol, 5 mM LA and 
2 mM SAH prior to flash-cooling in liquid nitrogen. 
 
Data Collection, Phasing and Structure Determination 
X-ray diffraction data were collected at Life Sciences Collaborative Access Team (LS-
CAT), Sector 21, Argonne National Laboratory. All data were indexed, integrated and scaled using 
either HKL2000 or AutoProc [20-23]. Both structures were determined by molecular replacement 
as implemented in the Phenix program suite [24]; for the CraLAMT-SAH structure, the 
coordinates of salicylic acid methyltransferase [25] (PDB ID: 1M6E) were used as search model, 
while for the CraLAMT-SAH-LA complex the refined coordinates of CraLAMT-SAH were used. 
In both cases, the resultant solutions were subsequently used as starting models for several rounds 
of automated model building using either the Phenix Autobuild wizard [26] or Buccanneer [27, 
28] as implemented in the CCP4 suite of programs [29], followed by rounds of manual rebuilding 
using COOT [30], combined with crystallographic refinement using REFMAC5 [31]. Ligands 
were built in COOT, and water molecules were added using the ARP/wARP solvent building 
software of the CCP4 suite [32], and confirmed by manual inspection. The quality of the in-
progress model was routinely monitored using both the free R factor [33] and MolProbity [34] for 
quality assurance. Data collection and refinement statistics are presented in Table 3. 1. For the 
CraLAMT-SAH-LA complex, clear electron density for loganic acid was only observed in one 
monomer. Although sparse density was observed in the other monomer, it was not adequate for 





Table 3. 1: Data collection and refinement statistics. (1. Highest resolution shell is shown in 
parenthesis, 2. Rsym = Σ |(Ii - <Ii> | Σ Ii where Ii = intensity of the ith reflection and <Ii> = mean 
intensity, 3. R-factor = Σ(|Fobs|-k|Fcalc|)/Σ |Fobs| and R-free is the R value for a test set of reflections 
consisting of a random 5% of the diffraction data not used in refinement.) 
 
 SAH SAH-LA 
   
Data collection   
Space Group P212121 P212121 
 a, b, c (Å) 57.8, 116.2, 136.3 58.4, 116.2, 136.6 
Resolution (Å) 35.0-2.2 116.2-1.95 
Rsym (%)[1,2] 12.8 (83.6) 10.9 (103.8) 
I/σ(I) 15.9 (2.0) 15.5 (2.1) 
Completeness (%) 100 (99.5) 99.6 (96.5) 
Redundancy 8.0 (7.4) 7.4 (7.5) 
Total reflections 50,471 504,320 




Resolution (Å) 34.1-2.2  68.3-1.95 
No. reflections used 45,501 68,223  
Rwork / Rfree[3] 18.5/22.9  17.5/21.9 
 
Number of atoms 
  
Protein 5687 5781  
Loganic acid - 26  
SAH 52 52  




Protein 35.9 30.8  
Loganic acid - 27.3  
SAH 23.9 20.1 




Bond lengths (Å) 0.009 0.008  



















Determination of Kinetic Parameters 
The kinetic parameters of the wild type protein were determined by detecting loganin 
formation by hydrophilic interaction liquid chromatography (HILIC). All enzyme reactions were 
performed in 20 mM Tris-HCl (pH 7.5) and 100 mM NaCl at 30 °C. For determination of the 
Michaelis-Menten parameters of the wild type enzyme for loganic acid, a 150 μl reaction volume 
contained the following components: 0.5 μM CraLAMT, 5 μM SAH nucleosidase, 400 μM SAM 
(Sigma-Aldrich), and various concentrations of loganic acid (Cambridge Chemicals). The 
reactions were stopped by addition of 300 μl acetonitrile (ACN), flash-frozen in liquid nitrogen, 
and dried for 1-1.5 h with a vacuum concentrator (Labconco CentriVap). The dried material was 
resuspended into 150 μl methanol/ACN (25/75 v/v), and the precipitated protein was removed by 
centrifuging for 4 min at 4 °C. 100 μl of the reaction mixture was then injected into a HPLC 
(Shimadzu prominence LC 20A) equipped with a Diol-HILIC column (YMC-Triart, 5 μm particle 
size, 4.6 x 250 mm). Solvent A consisted of 90% ACN and 10% of 25 mM Ammonium Acetate-
pH 5.3, and solvent B consisted of 70 % ACN and 30% of 25 mM Ammonium Acetate-pH 5.3 
(pH was adjusted prior to addition of the organic solvent). A gradient elution was applied as 
follows: 10 min of 10% B, 2 min gradient from 10% to 100% B, 25 min of 100% B, 2 min gradient 
from 100% back to 10% B and 20 min of 10% B. The flow rate was 1 ml/min throughout the 
procedure, and the separation of the reaction components was monitored at 240 nm.  
The area under the loganin peak was converted to concentration using a loganin calibration 
curve (Figure B. 1) generated with known concentrations of standard, using the same column and 
instrument. Control reactions without addition of the enzyme were also included and subtracted 
from the enzyme reactions. Based on the initial reaction rates, the apparent KM and Vmax values 
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were determined using the Michaelis - Menten function of Origin (OriginLab, Northampton, MA). 
Results are means ± SEM of triplicate experiments.  
The commercial SAM used in these experiments was further purified and quantified as 
previously described [35]. The stability and integrity of each reaction component after drying the 
samples with the vacuum concentrator was assessed by HILIC analysis of standards before and 
after drying them with the vacuum concentrator. All components were found to be stable during 
this process except for SAM which was converted to methylthioadenosine (MTA). The MTA peak 
was separated from the loganin peak (Table 3. 2) and did not affect our analysis. The identity of 
each peak was confirmed by high resolution liquid chromatography-mass spectrometry (LC/MS) 
(Table 3. 3). 
 
Table 3. 2: Retention times of each reaction component as analyzed by hydrophilic interaction 
liquid chromatography (HILIC). 
 









End-Point Activity Assay for CraLAMT Wild Type and Mutants 
For the activity of the wild type CraLAMT (Figure 3. 1B), 100 μl reactions containing 10 
μM CraLAMT, 5.5 μM Pfs, 1.2 mM SAM and 600 μM loganic acid were incubated at 30 °C for 
30 min, stopped by addition of 200 ul of ACN, vortexed, span down and analyzed by HILIC as 
described above (without drying the samples with the vacuum concentrator). 
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In order to compare the activity of the wild type CraLAMT and the mutants, reactions were 
analyzed by HILIC as described above. 150 μl reactions containing 0.5 μM enzyme, 5.5 μM SAH 
nucleosidase, 1.2 mM SAM and 600 μM (~ 2KM) loganic acid were incubated at 30 °C for 30 min. 
The reactions were stopped, treated and analyzed identically to the reactions for kinetic analysis. 
The activity of the mutants was expressed as percentage of loganin formation in respect to the wild 
type reaction (considered as 100%). For this purpose, the area under the loganin peak of the wild 
type reaction was considered as 100%, and the areas under the loganin peak of the mutants were 
converted to % of activity with the following equation: % of activity = (peak area of mutant) x 100 
/ (peak area of wild type). Control reactions without addition of the enzyme were also analyzed. 
Results are means ± SEM of triplicate experiments. 
 
High Resolution Liquid Chromatography-Mass Spectrometry (LC/MS) 
For high resolution LC/MS, the samples were analyzed by using the Q-Exactive MS system 
(Thermo. Bremen, Germany) in the Metabolomics Laboratory of Roy J. Carver Biotechnology 
Center, University of Illinois at Urbana-Champaign. Software Xcalibur 3.0.63 was used for data 
acquisition and analysis. The Dionex Ultimate 3000 series HPLC system (Thermo, Germering, 
Germany) used includes a DAD, a degasser, an autosampler, and a binary pump. The LC 
separation was performed with the same column, solvents and method used for the kinetic analysis. 
The autosampler was set to 15 °C. The injection volume was 40 μL. Mass spectra were acquired 
under both negative and positive electrospary ionization (ESI) (sheath gas flow rate, 65; aux gas 
flow rate: 20; sweep gas flow rate, 4; spray voltage, 3.5 kV; capillary temp, 300 °C; aux gas heater 
temperature, 500 °C. The resolution was set to 70,000. The AGC target was 1E6 with a maximum 
injection time of 200 ms. 
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Table 3. 3: High resolution LC/MS analysis of the reactions (10 uM CraLAMT, 5.5 uM Pfs, 1.2 
mM SAM, 600 uM loganic acid - 30 min at 30 °C) to further confirm the identity of each peak. 
 
Compound m/z 
Methylthioadenosine 298.096 [M+H]+ 
Loganin 391.159 [M+H]+ 
Adenine 136.062 [M+H]+ 
Loganic acid 375.130 [M-H]- 
SAM 399.144 [M+H]+ 
 
3.3 Results and Discussion 
 Using purified recombinant CraLAMT, we first confirmed that the enzyme was active 
(Figure 3. 1B), and determined the Michaelis - Menten kinetics parameters for the enzyme using 
loganic acid as the substrate (Figure 3. 1C). Because most SAM-dependent methyltransferases are 
known to be inhibited by product S-adenosyl-homocysteine (SAH), SAH nucleosidase was 
included in all of the assays (the Pfs SAH nucleosidase has a catalytic efficiency of 11.6 × 106 M-
1s-1) (Figure 3. 1B) [36]. The catalytic efficiency of CraLAMT (kcat/KM) was determined to be 996 
M-1s-1 (pH 7.5, 30 °C) (Figure 3. 1C), with a relatively high KM (315 ± 35 μM) compared to 
canonical plant SABATH O-methyltransferases [e.g. 23 ± 6.3 μM for the salicylic acid O-
methyltransferase from Clarkia breweri (CbSAMT) and 13 ± 5.1 μM for the indole-3-acetic acid 
O-methyltransferase from Arabidopsis thaliana (AtIAMT)] [25]. In a previous study [10], the KM 
of CraLAMT was reported to be about 50 times higher than the one reported here (14,700 ± 1,700 
µM at pH 7.5, 37 °C). However, our assays were performed using enzyme of high purity (>95%) 




In order to identify features that dictate accommodation of the glycosylated substrate, we 
determined the 1.95 Å resolution co-crystal structure of CraLAMT in complex with SAH and 
loganic acid. The core architecture of CraLAMT recapitulates the general features of other 
SABATH methyltransferases (Figure B. 2), such as the CbSAMT (PDB ID 1M6E) [25], the 
AtIAMT (PDB ID 3B5I) [37] and the xanthosine N-methyltransferase from Coffea canephora 
‘robusta’ (CcXMT) (PDB ID 2EG5) [38]. Specifically, the overall fold consists of a Rossmann-
Figure 3. 1: (A) Biosynthesis of strictosidine in Catharanthus roseus. Strictosidine is the precursor 
of many monoterpenoid indole alkaloids such as vinblastine (anticancer) and ajmalicine 
(antihypertensive). Numbering: (1) is 7-deoxyloganetic acid, (2) is 7-deoxyloganic acid, (3) is 
loganic acid, (4) is loganin, (5) is secologanin, (6) is tryptamine, and (7) is strictosidine. (B) 
Formation of loganin by CraLAMT as monitored by HPLC; elution profiles of reactions with (1) 
no CraLAMT, (2) no SAM and (3) CraLAMT + SAM. (C) Michaelis - Menten kinetic curve of 
wild type CraLAMT. Results are means ± SEM of triplicate experiments. Abbreviations: GPP for 
geranyl pyrophosphate, LA for loganic acid, SAM for S-adenosyl-methionine, SAH for S-




like domain that provides the residues for binding of the methyl donor appended to an all α-helical 
domain that encompasses the methyl acceptor substrate (Figure 3. 2A). The active site cavity of 
CraLAMT is remarkably more hydrophilic compared to the other known members of the family, 
and this difference reflects the differences in their substrates. Canonical SABATH 
methyltransferases utilize mainly bulky hydrophobic compounds, such as salicylic acid, benzoic 
Figure 3. 2: (A) Overall structure of CraLAMT; one monomer is shown in gray. In the other 
monomer, the Rossmann-like domain is shown in teal and the helical domain that binds the loganic 
acid (LA) is shown in purple.  S-adenosyl-homocysteine (SAH) and LA are shown in yellow 
sticks. (B) Difference Fourier map (Fo-Fc) contoured to 2.0 σ (blue) showing the bound SAH 
(colored in teal) and LA (colored in purple). (C, D) Stick representation showing the interactions 
with (C) the glucose moiety and (D) the iridoid ring of the LA. Hydrogen bonds are black dashed 
lines. (E) LIGPLOT [18] diagram of the LA interacting with its immediate environment. LA bonds 
are shown in purple, bonds within the LA environment in orange, hydrogen bonds are green dashed 




acid and indole-3-acetic acid while CraLAMT utilizes loganic acid, a compound with a hydrophilic 
glucose moiety and several polar groups.  
In the CraLAMT co-crystal structure, the carboxylate group of loganic acid is engaged and 
oriented for methyl transfer by a pair of conserved residues, Trp163 and Gln38, and the semi-
conserved His162 (Figure 3. 2D and Figure 3. 2E). Notably, the cavity of CraLAMT is different 
from the cavities of CbSAMT and CcXMT (Figure 3. 3), and is occupied by several polar residues 
that are within hydrogen bonding distance from loganic acid substrate. Additionally, a number of 
Tyr residues anchor the loganic acid in the correct orientation for productive methyl transfer 
(Figure 3. 3D). In contrast, the substrates in the structures of canonical SABATH enzymes are 
encircled by numerous aliphatic and aromatic residues (Figure 3. 3E and Figure 3. 3F), and are 
encompassed in cavities that are significantly smaller compared to the cavity of CraLAMT (Figure 
3. 3A-C); the volume of solvent accessible surface for CraLAMT is ~ 2256 Å3, while it is ~ 1964 
Å3 for CcXMT and ~ 1135 Å3 for CbSAMT as calculated by CastP [39]. 
The CraLAMT co-crystal structure also provides insight into the selectivity towards a 
glycosylated and hydroxylated iridoid ring substrate (Figure 3. 2C and Figure 3. 2E). The iridoid 
ring is positioned by Ile320 and Tyr159 which clamp the ring on opposite sides of the ring’s plane. 
The glucose moiety is anchored in the active site by Tyr37, which not only hydrogen bonds with 
the 4-hydroxyl group of glucose but also positions the glucose ring through hydrophobic 
interactions. In addition, Gln316 interacts with the 2-hydroxyl group and the 1-oxygen of the 
glucose, and the main chain amine of Ala241 is within hydrogen bonding distance from the 6-
hydroxyl of glucose. The specificity of CraLAMT towards a substrate containing a hydroxylated 
iridoid ring [10], may be due to the positioning of residues His245 and Gln273, which are poised 
to interact with the hydroxyl group of the iridoid ring (Figure 3. 2D and Figure 3. 2E). 
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To further investigate the significance of each of these residues on either the substrate 
binding or catalysis, we generated site-specific mutants and compared their activity with that of 
the wild type CraLAMT (Table 3. 4). The mutations Tyr159Ala and His162Ala abolished 
activity as no product formation could be detected even when 20-fold more enzyme was used. As 
Tyr159 clamps the iridoid ring and His162 interacts with the carboxylate group of the loganic acid, 
these two residues seem to be essential for proper positioning of the substrate for methylation. 
Mutation of any of the two residues that interact with the hydroxyl group of the iridoid ring 
(Gln273Ala and His245Ala) had an immense effect on the activity of the enzyme. The 
Gln273Ala variant was only residually active (1.7%), while 20 times more enzyme had to be 
Figure 3. 3: (A, B, C) Surface cut-away diagram showing that CraLAMT (A) has a larger cavity 
compared to (B) the xanthosine N-methyltransferase from Coffea canephora ‘robusta’ (CcXMT) 
[38], and (C) the salicylic acid O-methyltransferase from Clarkia breweri (CbSAMT) [25]. (D, E, 
F) Stick representation of the residues that form the cavity where the substrates of CraLAMT (D), 
CcXMT (E), and CbSAMT (F) bind showing that in CraLAMT a number of hydrophilic residues 
form the environment of the substrate in contrast to the aliphatic and aromatic residues that line 
the cavities of CcXMT and CbSAMT. Abbreviations: SAH for S-adenosyl-homocysteine, LA for 
loganic acid, XTS for xanthosine and SA for salicylic acid. 
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used in order to detect trace product formation with the His245Ala mutant. Finally, the mutation 
of Tyr37Ala, which anchors the glucose moiety, resulted in an inactive variant. These results 
further demonstrate that these residues recognize and position the glycosylated and hydroxylated 
iridoid substrate, and are in agreement with previous studies that showed that CraLAMT had no 
activity towards 7-deoxy-loganic acid as well as loganetic acid [7]. Mutation of Gln316Ala, the 
residue that is near the 2-hydroxyl group and the 1-oxygen of the glucose, had a significant effect 
on the activity (55.8%), but compared to the rest of the mutants it remained significantly active, 
indicating that although Gln316 plays important role in binding of the loganic acid, other 
interactions are more vital for recognition of the substrate. 
 
Table 3. 4: Activity of wild type CraLAMT and mutants. Results are means ± SEM of triplicate 
experiments. 
 
CraLAMT Activity (%) CraLAMT Activity (%) 
WT 100 H162A 0 
Y31F 1.4 ± 0.2 W163F 8.1 ± 0.8 
Y37A 0 Q273A 1.7 ± 0.5 
Q38A 3.1 ± 0.5 Q316A 55.8 ± 9.6 
Y159A 0 H245A 0 
 
Finally, the mutations Trp163Phe and Gln38Ala had a large effect on the activity of 
CraLAMT (8.1% and 3.1% respectively). As Gln38 and Trp163 are near the carboxylate of the 
substrate, the Gln38Ala and Trp163Phe mutations likely compromise binding and orientation 
of the substrate. Although in the crystal structure of CraLAMT with SAH and loganic acid the side 
chain of Gln38 is not in hydrogen bonding distance from the carboxylate group, the severe effect 
that the Gln38Ala mutation had on the enzyme activity suggests that Gln38 is involved in 
binding of the carboxylate group. This observation is in accordance with the conservation of this 
Gln in other carboxylic acid O-methyltransferases with the same fold, such as the CbSAMT (PDB 
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ID 1M6E) [25], the AtIAMT (PDB ID 3B5I),[14] and the fatty acid methyltransferase from 
Mycobacterium marinum (MmFAMT) (PDB ID 5F2K) [35].  
Compared to the xanthosine methyltransferase (CcXMT) which also accommodates a 
substrate with a sugar attached to it, the active site of CraLAMT is larger and more hydrophilic 
(Figure 3. 2C, Figure 3. 2D and Figure 3. 3B). The cavity of XMT is lined by a number of tyrosine 
residues whereas the cavity of CraLAMT is comprised of a number of glutamine and histidine 
residues in addition to a couple of tyrosine and small aliphatic residues (Figure 3. 3D and Figure 
3. 3E). Other adaptations of CraLAMT in order to incorporate a larger substrate like loganic acid 
include the incorporation of Pro227 at the C-terminus of beta-strand ß5 resulting in earlier 
termination of strands ß5, ß6 and ß7 (Figure 3. 4A and Figure 3. 4B); beta-strands ß5, ß6 and ß7 
are shorter in CraLAMT compared to CcXMT and CbSAMT allowing for a bigger cavity (Figure 






3.4 Concluding Remarks 
Our biochemical and structural analysis of CraLAMT illuminates how a SABATH 
methyltransferase has been adapted for the methylation of a large glycosylated substrate. Although 
Figure 3. 4: (A) Alignment of the primary sequences of CraLAMT and five other 
methyltransferases that share the same fold. The secondary structure of CraLAMT is also shown. 
(B) Comparison of active sites of CraLAMT (in blue), CbSAMT (in yellow) [25] and CcXMT (in 
teal) [38]. (C) Phylogenetic tree of the methyltransferases aligned in 3A, and structures of their 
substrates. Abbreviations: LjLAMT for loganic acid O-methyltransferase from Lonicera japonica, 
CbSAMT for salicylic acid O-methyltransferase from Clarkia breweri, CcXMT for xanthosine N-
methyltransferase from Coffea canephora ‘robusta’, AtIAMT for indole-3-acetic acid O-
methyltransferase from Arabidopsis thaliana, MmFAMT for fatty acid O-methyltransferase from 
Mycobacterium marinum , LA for loganic acid, XTS for xanthosine, IAA for indole-3-acetic acid, 
(3-OH)-FA for (3-hydroxy)-fatty acid and SA for salicylic acid. 
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CraLAMT shares the same fold with other members of the SABATH family, its active site cavity 
has evolved to accept a rather big and hydrophilic substrate. These structural data in conjunction 
with our mutation analysis, shed light on the molecular basis for the high specificity of CraLAMT 
for a glycosylated and hydroxylated iridoid ring. Finally, kinetic analysis of pure recombinant 
enzyme shows that pure recombinant CraLAMT is more efficient than previously reported [10], 
but the utilization of a solvated glycosylated substrate like loganic acid comes with a negative 
effect on the enzyme’s KM and, subsequently, its efficiency. This work provides a framework for 
further engineering studies aimed at diversification of the loganin scaffold towards the design of 
new classes of monoterpenoid indole alkaloids. 
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CHAPTER 4: INSIGHTS INTO THE MECHANISMS OF 
INHIBITION AND RESISTANCE BY THE 
PHOSPHONATE AMINO ACID (Z)-L-2-AMINO-5-
PHOSPHONO-3-PENTENOIC ACID (APPA)3 
4.1 Introduction 
Phosphonates are natural products containing a carbon-phosphorous (C-P) bond [1]. These 
C-P containing molecules inhibit enzymes which utilize phosphate esters and carboxylic acids by 
mimicking their substrates [1]. At a time when drug-resistant pathogens pose serious threat to 
human health, phosphonate natural products provide a pool of potential therapeutic candidates. 
Two such phosphonate containing compounds are rhizocticin and plumbemycin. 
Rhizocticin and plumbemycin are di- or tripeptides that contain the same phosphonic amino 
acid at their C-terminus, but differ at their N-terminus (Figure 4. 1A) [2, 3]. This unusual amino 
acid is (Z)-L-2-amino-5-phosphono-3-pentenoic acid (APPA), and is the active part of rhizocticin 
and plumbemycin. The N-terminal peptides facilitate active transport of these molecules into their 
target hosts. Upon entering the cell, host peptidases cleave the N-terminal residues to release 
APPA, which subsequently inhibits threonine synthase (ThrC) (Figure 4. 1B) and kills the cell [4]. 
Because thrC is an essential gene in bacteria and fungi, but is absent in humans, rhizocticin and 
plumbemycin are attractive as potential antimicrobials. Thus, understanding the mechanism of 
                                                          
3 This project is in collaboration with Dr. Manuel Ortega and the W.W. Metcalf group (UIUC). 
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inhibition of ThrC by APPA as well as how the producing organisms overcome APPA toxicity 
and attain resistance is important. 
There are two proposed mechanisms about the mode of inhibition of ThrC by APPA: 1) 
either APPA remains bound to the cofactor as a stable intermediate or 2) APPA forms a covalent 
adduct with the enzyme and the cofactor (Figure 4. 2) [5]. Currently, there is no direct evidence 
proving the one or the other mechanism. Results from previous experiments with ThrC from 
Escherichia coli were contradictive [5].  
Figure 4. 1: (A) Structure of rhizocticin and plumbemycin. The (Z)-L-2-amino-5-phosphono-3-
pentenoic acid (APPA) at their C-terminus is colored red. (B) Reaction catalyzed by threonine 
synthase. Upon release of the APPA inside the cell, APPA mimics O-phospho-L-homoserine and 
inhibits threonine synthase. 
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In addition to understanding the mechanism by which APPA inhibits threonine synthase, it 
is necessary to understand how the producing organisms are resistant to the inhibitor if we are 
interested in pursuing APPA containing compounds as potential antimicrobials. Currently, it is not 
clear how the native producer protects itself from APPA toxicity.  
In 2010, Borisova et al. identified the biosynthetic gene cluster of rhizocticin in Bacillus 
subtilis ATCC6633, and found that it contains a gene encoding for a putative threonine synthase 
(rhiB). They also found that B. subtilis ATCC6633 contains a second threonine synthase gene 
(thrC) in the threonine biosynthetic operon [4]. This led to their proposal that B. subtilis protects 
itself from APPA toxicity by having a second threonine synthase (RhiB) that is insensitive to the 
inhibitor. To test this hypothesis, Dr. Manuel Ortega from the W.W. Metcalf group (UIUC) 
expressed both B. subtilis ATCC6633 ThrC and RhiB in E. coli and showed that they both have 
threonine synthase activity (unpublished data). He also showed that APPA binds to ThrC at 1:2 
molar ratio ([enzyme]:[inhibitor]), while the same is not the case for RhiB (unpublished data).  
Figure 4. 2: There are two proposed mechanisms about the mode of inhibition of ThrC by APPA: 
1) either APPA remains bound to the cofactor as a stable intermediate or 2) APPA forms a covalent 
adduct with the enzyme and the cofactor. 
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To investigate the mechanism of inhibition of ThrC by APPA, we pursued crystallographic 
studies of ThrC in the presence of the inhibitor. In addition, we generated a homology model for 
RhiB in order to identify the differences in the active sites of RhiB and ThrC that are responsible 
for RhiB’s “resistance” to the inhibitor. Our results provide insights into the mode of inhibition of 
ThrC by APPA as well as how the native producer of rhizocticin is self-resistant to APPA. 
To investigate the mechanism of inhibition of ThrC by APPA, we pursued crystallographic 
studies of ThrC in the presence of the inhibitor. In addition, we generated a homology model for 
RhiB in order to identify the differences in the active sites of RhiB and ThrC that are responsible 
for RhiB’s “resistance” to the inhibitor. Our results provide insights into the mode of inhibition of 
ThrC by APPA as well as how the native producer of rhizocticin is self-resistant to APPA. 
 
4.2 Materials and Methods 
Chemical and Reagents  
All chemical reagents were purchased from Sigma-Aldrich unless otherwise noted. All of 
the material used for protein production and purification were purchased from GE Healthcare.  
 
Cloning and Site-Specific Mutagenesis  
Wild type ThrC (GenBank accession number EFG91998.1 - locus ADGS01000021) and 
RhiB (GenBank accession number EFG91528.1 – locus ADGS01000025) genes were cloned by 
Dr. Manuel Ortega (W. W. Metcalf group, UIUC) into a pET28b vector with an N-terminal His6 
tag. These plasmids were used as templates for the generation of the site-specific mutants by PCR 
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(primers shown in Table 4. 1). The integrity of all recombinant plasmids was confirmed by 
sequencing (ACGT, Inc.). 
 
Protein Expression and Purification of ThrC 
 Expression vectors bearing wild type or mutant ThrC were transformed into E. coli Rosetta 
2(DE3) cells for heterologous protein production. A 5 ml starter culture was inoculated in 2L 
Luria-Bertani growth medium supplemented with 25 µg/mL chloramphenicol and 50 µg/mL 
kanamycin. The culture was grown at 37 °C until the absorbance at 600 nm reached 0.6 – 0.8, at 
which point protein production was induced by addition of 0.3 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). The culture was then cooled to 18 °C and grown for an additional 
18 h. Cells were collected by centrifugation, resuspended in Buffer A (20 mM HEPES-NaOH, pH 
8.0, 500 mM NaCl, 10% glycerol), and lysed by multiple passages through a C5 Emulsiflex 
(Avestin) cell homogenizer. Following centrifugation of the lysate, the supernatant was applied to 
a 5 ml His-Trap (GE Biosciences) column that was previously equilibrated with Buffer B (20 mM 
HEPES-NaOH, pH 8.0, 1 M NaCl, 30 mM imidazole, 10% glycerol). The column was extensively 










Table 4. 1: Primers used for generation of ThrC and RhiB mutants. 
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washed with the same buffer and elution of specifically bound protein was carried out using a 
gradient of increasing imidazole concentration. Fractions containing protein of the highest purity 
(as determined by SDS-PAGE) were pooled and 5 mM pyridoxal 5'-phosphate (PLP) was added. 
After 1 h of incubation with PLP, samples were passed through a PD-10 desalting column (GE 
Healthcare) for buffer exchange (20 mM HEPES-NaOH, pH 8.0, 300 mM NaCl, 10% glycerol). 
For crystallization of ThrC, after the Ni2+ affinity column, the polyhistidine affinity tag was 
removed by overnight incubation with thrombin at 4 °C. Samples were further purified using size 
exclusion chromatography (Superdex Hiload 75 16/60) in a buffer of 20 mM HEPES-NaOH, pH 
7.5, 300 mM KCl. All samples were concentrated using a 10,000 Da molecular weight cutoff 
Amicon centrifugal filters, flash frozen in liquid nitrogen and stored at -80 °C. 
 
Protein Expression and Purification of RhiB 
Expression vectors bearing wild type or mutant RhiB were transformed into E. coli BL21 
cells containing the pGro7 plasmid for heterologous protein production. A 5 ml starter culture was 
inoculated in 2L Terrific Broth growth medium (12 g tryptone, 24 g yeast extract, 4 mL glycerol 
and 100 mL of 0.17M KH2PO4 and 0.72M K2HPO4 per Liter) supplemented with 25 µg/mL 
chloramphenicol and 50 µg/mL kanamycin. The culture was grown at 37 °C until the absorbance 
at 600 nm reached 0.8 – 1.0, at which point protein production was induced by addition of 0.3 mM 
IPTG and 0.8 g/L L-arabinose. The culture was then cooled to 18 °C and grown for an additional 
18 h. Cells were collected by centrifugation, resuspended in Buffer A and lysed by multiple 
passages through a C5 Emulsiflex (Avestin) cell homogenizer. Following centrifugation of the 
lysate, the supernatant was applied to a 5 ml His-Trap (GE Biosciences) column that was 
previously equilibrated with Buffer B. Fractions containing protein of the highest purity (as 
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determined by SDS-PAGE) were pooled and 5 mM pyridoxal 5'-phosphate (PLP) was added. After 
1 h of incubation with PLP, samples were passed through a PD-10 desalting column (GE 
Healthcare) for buffer exchange (20 mM HEPES-NaOH, pH 8.0, 300 mM NaCl, 10% glycerol). 
All samples were concentrated using a 10,000 Da molecular weight cutoff Amicon centrifugal 
filters, flash frozen in liquid nitrogen and stored at -80 °C.  
 
Kinetic Characterization of ThrC and RhiB 
Michaelis-Menten kinetics were performed by Dr. Manuel Ortega (W. W. Metcalf group, 
UIUC) using a coupled assay for the continuous monitoring of inorganic phosphate (Pi) release by 
the enzyme [6]. Briefly, in the presence of inorganic phosphate, 2-amino-6-mercapto-7-
methylpurine riboside (MESG) is converted enzymatically by purine nucleoside phosphorylase 
(PNP) to ribose 1-phosphate and 2-amino-6-mercapto-7-methylpurine. This conversion of MESG 
results in a shift in maximum absorbance from 330 nm for the substrate (MESG) to 360 nm for the 
product. This shift allows for continuous monitoring of Pi production by measuring the increase in 
absorbance at 360 nm. The following conditions were used: 50 mM HEPES-NaOH, pH 7.5, 100 
μM PLP, 200 μM MESG, 0.00375 U/μL PNP, and either 0.25 μM RhiB or 0.1 μM ThrC, and 
various concentrations of O-phospho-L-homoserine (PHSer). 
 
Binding of APPA 
Binding of the inhibitor to the enzyme was monitored spectrophotometrically by monitoring 
the formation of a chromophore at ~500 nm [5]. Absorption spectra of native and mutant enzymes 
were recorded every 5 min, after the addition of APPA, for total 30 min in 50 mM HEPES-NaOH 
(pH 7.5) and at enzyme concentrations of 2 μΜ. The reported ratios correspond to molar ratios of 
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[holoenzyme]:[APPA], and were calculated after estimation of the PLP content of each enzyme 
preparation. The spectra were obtained using an Epoch2 (BioTek) microplate UV-visible 
spectrophotometer at ambient temperature. 
 
Estimation of PLP content – holoenzyme concentration 
Protein concentrations were determined by measuring the absorbance at 280 nm using the 
molecular weights and extinction coefficients calculated by the ProtParam tool (ExPASY server) 
(Table 4. 2) [7]. In order to calculate the concentration of holo-RhiB and holo-ThrC in the protein 
preparations, the absorbance at 388 nm before (free PLP) and after (total PLP) the addition of 0.2 
M NaOH was measured, as previously described [8-11]. The difference between the two values 
corresponds to the PLP concentration that is bound to the enzyme (holoenzyme concentration). 
Free PLP has a maximum absorbance at 388 nm with an extinction coefficient of 6600 M-1 cm-1 
in 0.1 M NaOH [11].The ε388 of free PLP in 0.2 M NaOH was measured by using 40 μM and 80 
μM PLP, and was found to be ~ 6525 M-1 cm-1. All measurements were performed in triplicates. 
 
Table 4. 2: Extinction coefficients and molecular weights as calculated by ProtParam (ExPASY 
server) and used for determination of the concentrations of wild type and mutant ThrC and RhiB. 
Enzyme ε280 (M-1cm-1) x 103 MW (kDa) 
ThrC_WT 28.4 39.72 
ThrC_F132Y 29.9 39.73 
RhiB_WT 53.3 50.08 








Crystallization of ThrC 
Initial crystallization conditions were determined by the sparse matrix sampling method 
using commercial screens. Crystals of ThrC-APPA were grown using the hanging drop vapor 
diffusion method. Briefly, 1 μl of protein at 4 mg/ml concentration was incubated with 15 molar 
equivalents of APPA (1.5 mM) for 1.5 h at ambient temperature, mixed with 1 μl of precipitant 
solution (0.03 M MgCl2 hexahydrate, 0.03 M CaCl2 dihydrate, 18% v/v PEG 550 MME, 9% w/v 
PEG 20,000, 0.1 M MES/imidazole, pH 6.5), and equilibrated over a well containing the same 
precipitant solution at 9 °C. The crystals were sequentially soaked in precipitant solution 
supplemented with increasing concentrations of 20 and 30% ethylene glycol prior to vitrification 
by direct immersion in liquid nitrogen.  
The ThrC-Ala/ThrC-PLP crystals were pooled from the initial screening trays. Briefly, 0.2 
μl of protein at 6 mg/ml was mixed with 0.2 μl of MORPHEUS crystallization screen [12] 
condition H1 (0.2 M sodium L-glutamate, 0.2 M DL-alanine, 0.2 M glycine, 0.2 M DL-lysine HCl, 
0.2 M DL-serine, 10% w/v PEG 20 000, 20% v/v PEG MME 550, 0.1 M MES/imidazole, pH 6.5) 
using the sitting drop vapor diffusion method, and equilibrated over a well containing the same 
precipitant solution at 9 °C. The crystals were sequentially soaked in precipitant solution 
supplemented with increasing concentrations of 20 and 30% ethylene glycol prior to vitrification 
by direct immersion in liquid nitrogen.  
 
Data Collection, Phasing and Structure Determination  
X-ray diffraction data were collected at Life Sciences Collaborative Access Team (LS-
CAT), Sector 21, Argonne National Laboratory. All data were indexed, integrated and scaled using 
AutoProc [13]. Both structures were determined by molecular replacement as implemented in the 
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Phenix program suite [14]; for the ThrC-PLP/ThrC-Ala structure, the coordinates of threonine 
synthase from Aquifex aeolicus Vf5 (59% sequence identity, 77% sequence similarity, 97% cover, 
PDB ID: 2ZSJ) were used as search model, while for the ThrC-APPA complex the refined 
coordinates of ThrC-PLP/ThrC-Ala were used. In both cases, the resultant solutions were 
subsequently used as starting models for several rounds of automated model building using Phenix 
Autobuild [15] and Buccaneer [16-18], followed by rounds of manual rebuilding using Coot [19], 
and refinement using either Phenix Refine [20] or REFMAC5 [21]. Water molecules were added 
during refinement with Phenix Refine, and confirmed by manual inspection. In all cases, the 
quality of the in-progress model was routinely monitored using both the free R factor [22] and 
MolProbity [23] for quality assurance.  
 
Homology Modeling of RhiB 
The structure of the RhiB protein was modeled from its primary amino acid sequence by 
using the structure-based homology modeling tools Phyre2 [24] and SWISS-MODEL [25, 26]. 
For the Phyre2 model, the intensive mode of Phyre2 was selected and a model was generated based 
on several templates. For the SWISS-MODEL generated models, several different templates were 
used (PDB IDs: 2C2G, 3AEY, 3AEX) including the ThrC-APPA and ThrC-PLP since a 
conformational change that closes the active site occurs upon binding of the substrate. All models 
were superimposed with each other and with the ThrC-APPA structure, and were used to identify 
differences between the active sites of ThrC and RhiB. The active site of all models was identical. 
Differences were observed between the models generated by apo-templates and the models 
generated by templates in a closed conformation. The model generated by SWISS-MODEL using 
the ThrC-APPA structure as template was finally selected and is shown in the figures. 
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Inhibition Assays – 31P NMR 
Enzyme inhibition assays were carried out at 30 °C in 50 mM HEPES-NaOH (pH 7.5). In a 
final volume of 400 μL, 0.5 μM holo-ThrC wild type and mutant was pre-incubated with 2.5 μM 
APPA for 1 h at 30 °C, and then 1.6 mM PHSer (~5 x KM) was added. For RhiB wild type and 
mutant, 3 μM holoenzyme was pre-incubated with 15 μM or 60 μM APPA for 1 h at 30 °C, and 
then 4 mM PHSer (~5 x KM) was added. After 30 min incubation of the enzymes with PHSer, the 
samples were passed through 10,000 Da molecular weight cutoff Amicon centrifugal filters, and 
300 μL of the reactions were removed and mixed with 300 μL D2O. For quantification during 31P-
NMR, 0.5 mM of dimethylphosphinic acid was added as internal standard in all samples, and 
phosphate release was used for the calculation of product formed by each enzyme. The activity of 
the enzymes in the presence of APPA was expressed as percentage of PHSer consumed in respect 
to the corresponding reaction that contained no APPA (considered as 100%). Results are means ± 
SEM of triplicate experiments. NMR analyses were carried out in the Carl R. Woese Institute for 




4.3 Results and Discussion  
Enzyme Activity and Michaelis-Menten Kinetics 
The threonine synthase activity of ThrC and RhiB from B. subtillis ATCC6633 was 
confirmed by Dr. Manuel Ortega (W. W. Metcalf group, UIUC) by detection of threonine utilizing 
1H-NMR (unpublished data). In addition, Dr. Ortega obtained the Michaelis-Menten parameters 
for each of these enzymes; the housekeeping threonine synthase, ThrC, was found to be ~7 times 
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more efficient than RhiB, the enzyme which we hypothesized to be insensitive to APPA 
(unpublished data). 
 
Binding of APPA 
Binding of the inhibitor to the enzyme was monitored spectrophotometrically by monitoring 
the formation of a chromophore at ~500 nm, as previously reported with experiments performed 
with the threonine synthase from E. coli [5]. The initial binding experiments were performed by 
Dr. Ortega. Briefly, ThrC and RhiB were incubated with inhibitor at 1:2 molar ratio 
([enzyme]:[APPA]) for 15 min, and a shift in absorbance from the internal aldimine to ~519 nm 
was observed only in the case of ThrC (unpublished data). These data indicated that APPA binds 
to ThrC, but not to RhiB.  
 
Structure of ThrC 
The overall structure of ThrC is similar to other Fold Type II PLP-dependent enzymes 
(tryptophan synthase family); these enzymes are active as homodimers with two distinct active 
sites [27, 28]. The asymmetric unit is composed of two monomers, one in an open conformation 
with the PLP bound to the active site Lys59 through an aldimine linkage, and one in the closed 
conformation. In the closed conformation, a ligand was found to be bound to the cofactor even 
though no substrate was added. However, the crystallization condition contained a mixture of 
amino acids (0.2 M sodium L-glutamate, 0.2 M DL-alanine, 0.2 M glycine, 0.2 M DL-lysine HCl, 
0.2 M DL-serine). After electron density swap experiments, the substrate bound to the PLP was 
identified as alanine. A phosphate group was also bound in the active site of the ThrC-Ala 
monomer. This phosphate group most likely stayed bound to the enzyme throughout the 
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purification of ThrC. The observation of two conformations is in agreement with previous studies; 
upon binding of the substrate, the active site of the enzyme closes to control proton transfers and 
solvent accessibility during the reaction [28-30]. 
 
Mode of Inhibition 
In the presence of APPA, ThrC crystallized as a dimer of dimers, and the crystals were 
orange, in agreement with the observed shift in the absorption spectrum of the enzyme after 
binding of the inhibitor [5]. The enzyme was incubated with 15 molar equivalents of APPA (1.5 
mM) for 1.5 h at ambient temperature in order to make certain that the reaction with APPA had 
fully proceeded. The inhibitor was present in all 4 molecules in the asymmetric unit and was clearly 
bound to the cofactor (Figure 4. 3). As protons can be added and subtracted at different positions 
Figure 4. 3: Crystal structure of ThrC with APPA bound in the active site. (A) Ribbon 
representation of the ThrC-APPA homodimer. The C-terminal of each monomer crosses over to 
the other monomer. One monomer is colored purple and the other monomer is colored gray. (B) 
Difference Fourier map (Fo-Fc) contoured to 2.0 σ (green) showing the bound PLP-APPA adduct
(colored in purple). 
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during the reaction, and the covalent adduct couldn’t been isolated, the exact identity of the PLP-
APPA adduct in the crystal structure could not be identified. Nevertheless, it is clear from the 
structural data that the inhibitor remains bound to the cofactor and does not form a covalent adduct 
with an active site residue (mechanism 1, Figure 4. 2). 
 
Binding of APPA to RhiB 
The support of mechanism 1 (Figure 4. 2) by the crystal structure of ThrC-APPA raises the 
question why APPA does not bind to RhiB. Since no active site residue forms a covalent adduct 
with the inhibitor, then why does the inhibitor not bind to the cofactor in the active site of RhiB. 
To answer this question, we hypothesized that APPA can bind to RhiB, but the Ki for RhiB is 
Figure 4. 4: Absorption spectra of ThrC and RhiB before and after the addition of APPA. The 
molar ratios indicated correspond to [holoenzyme]:[APPA]. The formation of a chromophore at 
~519 nm indicates binding of the inhibitor to the cofactor. Binding of APPA to RhiB was observed 
at a molar ratio 1:8 and was slower compared to ThrC. 
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much higher than the Ki for ThrC. This lower affinity 
of the inhibitor towards RhiB would result in the latter 
being insensitive to APPA in physiological conditions 
(low APPA concentrations). To investigate this 
hypothesis, we recorded the absorption spectrum of 
RhiB in the presence of different concentrations of 
APPA, and observed binding of APPA to RhiB at a 
molar ratio of 1:8 ([holoenzyme]:[APPA]) (Figure 4. 
4). This observation is in agreement with our 
hypothesis that RhiB is insensitive to APPA at 
physiological concentrations because the Ki for the 
inhibitor is much higher compared to the Ki of ThrC.  
In the absence of a crystal structure of RhiB, we generated a homology model for RhiB, and 
performed a sequence analysis of RhiB homologs in order to identify the differences in the active 
sites of RhiB and ThrC that are responsible for different affinities towards APPA. Comparing the 
two active sites, the residues that bind the cofactor were conserved. The only obvious difference 
was the substitution of Phe132 in ThrC by Tyr188 in RhiB (Figure 4. 5). In ThrC, Phe132 is 3.8 
Å away from the C5 (carbon of the phosphonic group) of APPA, which is the position of the O5 
(oxygen of the phosphate group) in PHSer. This led us to the hypothesis that introduction of a 
hydroxyl group in that position may affect binding of the inhibitor.  
To investigate this hypothesis, we generated the ThrC_Phe132Tyr and 
RhiB_Tyr188Phe mutants and recorded the absorption spectra before and after the addition of 
the inhibitor (Figure 4. 6). The formation of a chromophore at ~ 514 nm indicated binding of APPA 
Figure 4. 5: Phe132 in ThrC (purple) is 
substituted by Tyr188 in RhiB (grey). 
Introduction of a hydroxyl group in close 
proximity to C5 of APPA may affect 







to both mutants at a molar ratio of 1:1 [holoenzyme]:[APPA]. These results indicate that Tyr188 
in RhiB may play a role in the lower binding affinity for APPA, but may not be the only difference 
in the active site to be accounted for the different affinities. 
 
Inhibition by APPA 
In addition to the binding experiments, we performed an end-point assay and measured the 
activity of each enzyme variant in the absence and presence of the inhibitor (Figure 4. 7). In the 
case of ThrC, the activity of the wild type enzyme was about 20% in the presence of APPA while 
the ThrC_Phe132Tyr variant was still 80% active. In addition, wild type RhiB was 100% active, 
even in the presence of 4 times more APPA compared to ThrC wild type and mutant, while the 
RhiB_Tyr188Phe mutant was ~ 85% active. Substitution of Phe132 by Tyr in the APPA 
sensitive ThrC resulted in an enzyme that was less sensitive to the inhibitor, and substitution of 
Tyr188 by Phe in the APPA “insensitive” RhiB generated a variant with some sensitivity to the 
Figure 4. 6: Absorption spectra of ThrC and RhiB mutants before and after the addition of APPA. 
The molar ratios indicated correspond to [holoenzyme]:[APPA]. The formation of a chromophore 
at ~514 nm indicates binding of the inhibitor to the cofactor. 
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inhibitor. These results indicate that substitution of Phe132 by Tyr in the proximity of C5 of APPA 
has an effect on binding of the inhibitor. 
 
4.4 Concluding Remarks 
Our structural data provide direct evidence about the mode of inhibition of threonine 
synthase by APPA. In conjunction with our biochemical data, they support the hypothesis that the 
Figure 4. 7: Activity of ThrC and RhiB wild type and mutants in the absence and presence of 









































































































































rhizocticin producer protects itself from APPA toxicity by having a second threonine synthase 
(RhiB) that is “insensitive” to the inhibitor. Our mutagenesis study suggests that the introduction 
of a hydroxyl group in RhiB (substitution of Phe132 by Tyr) in close proximity to the C5 of APPA 
has an effect on the binding of the inhibitor. However, this may not be the only difference in the 
active sites of ThrC and RhiB to be accounted for APPA resistance.  
Further experiments that include kinetic analyses of the mutants for PHSer and rate constants 
of binding for APPA would further elucidate the role of PheTyr substitution. Nevertheless, our 
data provide evidence that RhiB is a threonine synthase that is insensitive to APPA and that Tyr188 
in the active site of RhiB affects the binding of the inhibitor. 
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APPENDIX A: SUPPORTING INFORMATION FOR 
CHAPTER 1 
MmFAMT behaves as a homodimer in solution 
To determine whether MmFAMT exists as a homodimer in solution as it does in the crystal 
lattice, we performed size exclusion chromatography (Superdex Hiload 75 16/60) for proteins of 
known molecular weights (carbonic anhydrase; ~ 29 kDa, albumin; ~ 66 kDa, and alcohol 
dehydrogenase; ~ 150 kDa - Sigma-Aldrich), and generated a standard curve (Figure A. 1B). The 
column was equilibrated in a buffer of 20 mM HEPES-KOH, pH 7.5, 300 mM KCl, and 3 mg/ml 
of each standard were injected and ran through the column at a flow rate of 1 mg/ml. Similarly, 3 
mg/ml of MmFAMT were loaded and ran through the same column under the same conditions 
(buffer and flow rate). MmFAMT (~40.5 kDa) eluted at 55.82 ml (Figure A. 1A), elution volume 
that corresponds to a molecular weight of approximately 100 kDa. This molecular weight is in 




Figure A. 1: (A) Elution profile of MmFAMT using a Superdex Hiload 75 16/60 column (Ve= 
55.82ml). (B) Standard curve generated by the elution volumes of protein standards; alcohol 
dehydrogenase is ~ 150 kDa, albumin ~ 66 kDa, and carbonic anhydrase ~ 29 kDa. MmFAMT 
(~40.5 kDa) eluted at 55.82 ml, elution volume that corresponds to a molecular weight of 
approximately 100 kDa. This molecular weight is in agreement with a dimer of MmFAMT with 




Figure A. 2: Superposition of the active sites of wild-type (cyan) and Q154A (yellow) MmFAMT 
showing the movement of the C10-hydroxy substrate as a consequence of the mutation. 
Figure A. 3: Comparison of the overall dimeric structure of (A) MmFAMT bound to octanoate 
(C8 shown in CPK representation) with those of (B) salicylic acid O-methyltransferase bound to 
salicylic acid (SA shown as yellow sticks) [1] and (C) indole-3-acetic acid O-methyltransferase 
[2]. One monomer is colored in gray, and the capping domain of the other monomer is colored in 





Figure A. 4: Sequence alignment of mycobacterial proteins that are 50 - 80% identical with 
MmFAMT and with one another. The alignment was performed by the Clustal Omega tool 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) using the default settings. Only parts of the sequences 
involved in substrate binding are shown. The UniProtKB (http://www.uniprot.org/) IDs of the 
sequences are listed in Table A. 3. 
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Table A. 1: Primers used for amplification of wild type MmFAMT and generation of mutants. 
 
Primer name Sequence (5'-3') 











Table A. 2: Percentage of salicylic acid (SA) and octanoic acid (C8) converted into their O-
methylated counterparts (Me-SA and Me-C8 respectively) by the wild type MmFAMT as 
determined by gas chromatography-mass spectrometry (GC/MS) in end point assays.  
 
Reaction %SA %C8 
1 23 17 
2 18 19 
3 26 17 




Table A. 3: UniProtKB (http://www.uniprot.org/) IDs of mycobacterial sequences used for the 
alignment shown in Figure A. 4. 
 
UniProt ID Organism Length 
A0A049EBD3 Mycobacterium avium XTB13-223 370 
A0R0D4 Mycobacterium smegmatis (strain ATCC 700084 / mc(2)155) 360 
A0A099CRQ3 Mycobacterium rufum 361 
A1TBK2 Mycobacterium vanbaalenii (strain DSM 7251 / PYR-1) 361 
A4T267 Mycobacterium flavescens (strain ATCC 700033 / PYR-GCK) 360 
B2HHT4 Mycobacterium marinum (strain ATCC BAA-535 / M) 368 
D5P794 Mycobacterium parascrofulaceum ATCC BAA-614 364 
F5Z029 Mycobacterium sp. (strain JDM601) 359 
G4I3C9 Mycobacterium rhodesiae JS60 370 
G7CDV0 Mycobacterium thermoresistibile ATCC 19527 364 
G8RLT8 Mycobacterium rhodesiae (strain NBB3) 361 
I0S4R3 Mycobacterium phlei RIVM601174 364 
I4BL79 Mycobacterium chubuense (strain NBB4) 361 
K5BJJ8 Mycobacterium hassiacum DSM 44199 362 
L0IY74 Mycobacterium smegmatis JS623 350 
V5XG76 Mycobacterium neoaurum VKM Ac-1815D 357 
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Figure B. 1: Standard curve generated by loganin standards of known concentrations, and used for 
the determination of the concentration of loganin produced by CraLAMT in order to perform 













Figure B. 2: Comparison of the overall dimeric structure of (A) CraLAMT with that of (B) salicylic 
acid O-methyltransferase from Clarkia breweri (CbSAMT) [1] and (C) xanthosine N-
methyltransferase from Coffea canephora ‘robusta’ (CcXMT) [2]. One monomer is colored in 
gray, the Rossmann-like domain is colored in teal, and the capping domain of the other monomer 
is shown in different colors. Bound S-adenosyl-homocysteine (SAH, shown in yellow) and 
substrates are shown as space-filling models. Abbreviations: LA for loganic acid, SA for salicylic 






Figure B. 3: (A) Difference Fourier map (Fo-Fc) contoured to 2.0 σ (blue) showing the bound 
SAH (colored in teal). (B) LIGPLOT[3] diagram of the SAH interacting with its immediate 
environment. SAH bonds are shown in blue, bonds within the SAH environment in orange, 
hydrogen bonds are green dashed lines, and residues in hydrophobic contact with SAH are 
represented by red semicircles with radiating spokes. 
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Table B. 1: Primers used for amplification of wild type CraLAMT and generation of site-directed 
mutants. 
Primer Name Sequence ( 5’  3’) 















Table B. 2: Extinction coefficients and molecular weights as calculated by ProtParam [4] 
(ExPASY server) and used for determination of the concentrations of wild type CraLAMT and 
mutants. 
 
CraLAMT variant ε280 (M-1cm-1) x 103 MW (kDa) 
WT 21.9 43.08 
Y31F 20.4 43.07 
Y37A 20.4 42.99 
Q38A 21.9 43.03 
Y159A 20.4 42.99 
H162A 21.9 43.02 
W163F 16.4 43.04 
Q273A 21.9 43.03 
Q316A 21.9 43.03 
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